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ABSTRACT 
Lipid metabolism plays a prominent role in the survival of Mycobacterium tuberculosis 
(MTB) in both the macrophage and mammalian hosts.  A central question in the 
reconstruction of lipid metabolism in MTB is the key regulatory programs responsible for 
changes in this metabolism under different conditions. One of the most studied 
conditions is hypoxia (oxygen deprivation) as adaptations to hypoxia are thought to play 
an important role in MTB pathogenesis and latency. To identify temporal trends during a 
hypoxic time course and associate them with possible regulators, expression data was 
clustered into paths using DREM algorithm and available ChIP-Seq data for over 80 
transcription factors (TFs). The degree to which expression patterns might reflect the 
direct action of transcription factors was assessed by evaluating the consistency 
between the path, the expression of each TF binding genes in the path, and the 
predicted regulatory role of the TF from the regulatory network. DosR was correctly 
identified as an activator of the path corresponding almost entirely to its regulon. 
Rv0081 was found to be a candidate high level regulator broadly predictive of the 
overall expression of sets of genes during hypoxia and re-aeration. 
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An essential part of the continued survival of MTB in the host is due to its adaptation to 
the phagosomal compartment of the macrophage where the bacterium faces hypoxic as 
well as other stresses. Using the same approach and several time course expression 
data sets available for MTB in macrophage cultures, macrophage temporal expression 
models were built and compared to the hypoxia model. Similar trends were found in the 
expression of genes involved in respiration, cholesterol catabolism and methylcitrate 
cycle. In contrast, a group of genes responsible for the synthesis of complex cell wall 
lipids (PAT/DAT and SL-1) were up-regulated in the macrophage models and 
downregulated in the hypoxic model. PhoP was predicted as a potential main regulator 
of these genes as a result of pH change which takes place in the macrophage 
environment but not during hypoxia. 
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Chapter 1. Introduction 
1.1. Mycobacterium tuberculosis (MTB) – the causative agent for tuberculosis (TB) 
Mycobacterium tuberculosis (MTB) still remains a pathogen that causes millions of 
deaths each year [1-5]. The bacterium is primarily transmitted via the respiratory 
route. Infection occurs in the lungs but the organism can occupy any organ via 
hematogenous spread.  Being exposed to MTB, 30% of individuals become infected, 
with about 40% of these individuals developing primary active tuberculosis (TB) and 
60% developing latent infection. 2–23% of immunocompetent patients with latent TB 
will reactivate at a later date, while patients with HIV develop reactivation TB at a 
rate of around 5-10% per year [1]. Part of what makes MTB such a successful 
pathogen is its ability to survive within the host for months to decades in an 
asymptomatic latent state and to adapt to a wide range of conditions inside and 
outside the host. 
1.2. Latency, dormancy and persistence 
Three terms are commonly used when describing MTB and TB pathogenesis: 
latency, dormancy and persistence [5]. Latency was defined by Amberson as ‘‘the 
presence of any TB lesion which fails to produce symptoms of its presence’’ or can 
be also referred as the disease itself in its asymptomatic state [1, 4]. Without 
antibiotic treatment, chronic or latent infection is thought to be the typical outcome of 
TB infection. Latent TB can reactivate after years or even decades of subclinical 
persistence, leading to progressive disease and active transmission of the pathogen.  
Dormancy is used to describe both TB as a disease as well as the metabolic state of 
the pathogen. TB lesions are described as active if the associated pathology is 
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progressing and dormant if it’s healing. Active lesions are characterized by easily 
detectable populations of acid-fast, culturable MTB. The term dormancy is also often 
associated with an in vitro model of MTB growth under hypoxic (oxygen-depleted) 
conditions developed first by Wayne [4]. This model is thought to approximate the 
state of MTB surviving in closed, necrotic lesions during clinical latency. 
The term persistence literally means “continuing to survive steadfastly under the 
immune response of the organism and adverse conditions”. MTB, as a pathogen, 
can persist on several levels. On the cellular level, mycobacteria reside within 
macrophages, cells which eliminate pathogens and other foreign material from the 
body. At a more systematic level, MTB is able to avoid being eliminated from the 
human host despite the development of a vigorous immune response. Another 
important form of MTB persistence is the slow rate at which the bacterium is cleared 
by anti-TB drugs. 
1.3. Modeling persistence in animals 
The most commonly used model for studying TB is the mouse. Once delivered, MTB 
grows relatively unimpeded in the lungs (and spleen) of mice for the first 2 to 4 
weeks after which the immune system controls the growth of the bacteria and their 
numbers reach a plateau. The immune response is not able to substantially reduce 
the bacterial numbers in the lung or spleen and as a result a persistent or chronic 
infection ensues and is maintained for many months. Despite relatively high levels of 
bacteria in the lungs, the mice do not show clinical signs of disease and can survive 
for more than a year postinfection. This is an attractive model as it represents 
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equilibrium between host and bacillus and the bacterial numbers are controlled by 
the immune response, which holds for the human latent infection [3, 5, 22]. 
Another mouse latent TB model, so called “Cornell model”, involved treating MTB 
infected mice with antimycobacterial drugs, which reduced the bacterial burden to 
undetectable levels. This model is attractive because of that low bacterial burden. 
But introduction of antibiotics to reduce the bacterial numbers does not mimic the 
situation in natural human latent TB and may affect the development of a protective 
immune response. However, some groups have used variations of this model to 
study persistence and reactivation of mycobacteria in the host, as well as vaccination 
of latently infected hosts [5]. 
Other animal models for the study of TB include guinea pigs, rabbits and non-human 
primates. The rabbit model is the closest to imitating human TB in terms of tissue 
pathology and disease progression. Still, rabbit as well as the other animal models 
are not widely used compared to the mouse model [5, 22]. 
1.4. Macrophage infection 
 MTB is able to survive within the host and cause disease because of its remarkable 
capacity to survive within the hostile environment of the macrophage [9, 10]. 
1.4.1. Formation of the granuloma 
Once the infectious bacilli are inhaled as droplets from the atmosphere and reach the 
lung, they are phagocytosed by alveolar macrophages and induce a localized 
proinflammatory response that leads to the recruitment of mononuclear cells from 
neighboring blood vessels. These cells form the granuloma, or, tubercle, which is the 
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signature structure of TB. The granuloma consists of infected macrophages 
surrounded by foamy macrophages and other mononuclear phagocytes. The 
periphery of the structure is mantled by lymphocytes associated with a fibrous cuff of 
collagen and other extracellular matrix components. This tissue response is typical 
for the ‘containment’ phase of the infection in which there are no overt signs of 
disease and the host does not transmit the infection to others. In the later stages, the 
granuloma develops a marked fibrous sheath. Containment usually fails when the 
immune status of the host changes, which is usually cause by old age, malnutrition 
or co-infection with HIV (any condition that impairs the function of CD4+ T cells). As 
a result, the granuloma caseates (decays into a structureless mass of cellular 
debris), ruptures and spills thousands of viable, infectious bacilli into the airways [9]. 
 Both activated and non-activated macrophages coexist within granulomas, with the 
activated macrophages processing and representing mycobacterial antigens to the 
surrounding lymphocytes. As for MTB itself, the precise status of the bacteria within 
granulomas is not clear. They may exist as actively dividing bacilli or in a “dormant” 
state [10]. And it’s possible that both actively dividing and dormant bacilli can occur 
within the same infected individual depending on the stage of the disease [14, 15]. 
1.4.2. Mycobacterial prevention of phagosome-lysosome fusion 
MTB is able to survive within the phagosome by arresting its normal maturation. 
Instead to pH 5 the phagosomes containing the bacteria acidify only to pH 6.4 
limiting the fusion with the pre-formed lysosomes [9, 10]. The modulation of the 
phagosome seems to be mediated by both cell-wall lipids and other bacterial 
effectors [9]. MTB has a thick cell wall consisting of unique lipid and glycolipids 
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moieties. The glycolipids of the bacteria can interfere with the phagosome fusion 
through blocking a normal host trafficking event that is regulated by 
phosphatidylinositol 3-phosphate (PIP3). PI3P is a host membrane component that is 
essential for phago-lysosome biosynthesis [26]. PIP3 is thought to present a docking 
site for several proteins involved in the maturation of the phagosomes into 
lysososmes [10]. MTB interferes with this trafficking event by preventing PIP3 
accumulation on phagosomal membranes [27]. There are two strategies used for the 
process. First, MTB interferes with the activity of the PI3 kinase hVP34, preventing 
the generation of PIP3 on the phagosomal membrane and blocking phagosome-
lysosome fusion. This inhibitory activity was proposed to be mediated by the 
mycobacterial cell-wall component lipoarabinomannan (LAM) since the addition of 
purified LAM was sufficient to prevent lysosomal delivery [28]. It remains unclear how 
LAM-mediated blockage is regulated. A second strategy relies on the prevention of 
PIP3 accumulation on phagosomes by the activity of a phosphatase, termed SapM 
[29]. SapM is presumably released within the host cell cytosol upon infection, where 
it may hydrolyze PIP3 on phagosomal membranes [30]. Apart from lipid 
phosphatases, MTB  also possesses protein phosphatases (PtpA and B [31]) that 
interfere with host trafficking processes. 
One of MTB serine/threonine kinases, PknG, is essential for the prevention of 
phagosome-lysosome fusion, as the overexpression of a mutant form of PknG 
results in lysosomal delivery of the bacteria [32]. As several factors that are involved 
in the regulation of intracellular transport reactions require phosphorylation, it is likely 
that PknG acts by phosphorylating a host molecule, thus preventing the activity of 
this host factor in carrying out phagosome-lysosome fusion. 
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Apart from producing virulence factors such as SapM and PknG, MTB has evolved a 
mechanism to interfere with host cell signaling. A protein, referred to as coronin 1 (or 
TACO) is recruited to phagosomes containing live bacilli, but rapidly released from 
phagosomes containing killed mycobacteria, which suggests that coronin 1 is an 
important host factor that specifically prevents the lysosomal delivery and death of 
the bacilli inside macrophages [33, 34]. The protein prevents phagosome-lysosome 
fusion by regulating calcium-dependent signaling processes. When macrophages 
are infected with MTB, a sustained calcium flux is generated that is dependent of the 
presence of coronin 1. The coronin 1-dependent cytosolic influx of calcium activates 
the calcium-dependent phosphatase calcineurin. The activation of calcineurin is 
required for blocking phagosome-lysosome fusion [35]. The activated protein links up 
to several downstream signaling cascades, ranging from the transfer of 
transcriptional factors to the nucleus to dephosphorylation of proteins involved in 
endocytosis [36, 37].The mechanism of coronin 1 recruitment to the mycobacterial 
phagosome and the precise activity of calcineurin required to prevent lysosomal 
delivery of mycobacteria are unknown. 
Mycobacterial glycolipids also play an important role in the subversion of 
macrophage activation. The abundant cell-wall component LAM as well as its 
glycosylated forms (manLAM) can modulate signaling pathways that induce 
macrophage activation, including interferon-γ-mediated gene expression, TLR 
activation, and phagosome-lysosome fusion [38]. LAM can also block the activation 
of an important kinase (MAPK) that is downstream of various stimuli that cause 
macrophage activation [39]. 
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In addition, modulation of bacterial metabolic pathways can lead to a long-term 
survival within macrophages. When bacteria enter a nutrient-poor environment 
similar to the one that can occur within macrophage phagosomes, they become 
restricted to fatty acids as their carbon source. An activation of the glyoxylate shunt 
pathway follows, which facilitates carbon retention through de novo synthesis of 
carbohydrate [40]. The first step in this pathway is catalized by isocitrate lyase (icl1) 
which is an essential enzyme for the establishment of a persistent infection of MTB. 
Another cell envelope component that contributes to acid resistance and virulence of 
MTB is the outer membrane protein OmpATb [41, 42]. An OmpATb mutant showed 
delayed growth at pH 5.5 in vitro, and reduced growth in macrophages and mice. 
The mechanism by which OmpATb confers acid resistance is unknown. In lipid 
bilayers this protein exhibits pore-forming activity, which is pH-sensitive as the 
channel has a propensity to close at low pH [42]. 
 Two other genes that may have a role in acid resistance are Rv3671c and Rv2136c 
[41]. Their transposon mutants were impaired in their ability to maintain a neutral 
intrabacterial pH during acid challenge and inside activated mouse macrophages 
[43]. Rv3671c encodes a membrane-associated serine protease and might protect 
MTB against acid by modifying the bacterial cell envelope, regulating protein or lipid 
quality control and/or serving in signaling pathways that help the bacteria to resist 
extracellular stress. Rv2136c is a putative homologue of Escherichia coli’s UppP, an 
undecaprenol pyrophosphate phosphatase involved in peptidoglycan biosynthesis 
[41]. The exact mechanisms by which these two genes protect against acid stress 
and support virulence is still unknown. 
8 
 
 
 
Mg2+ transport is another potential stress-resistance factor as an MTBΔmgtC mutant 
was attenuated for growth in macrophages and mice. MgtC is a putative Mg2+ 
transporter and Mg2+ might be required at low pH for the maintenance of cell wall 
integrity, as a cofactor for enzymes that become important during acid stress or for 
the function of Mg2+-dependent ATPase involved in extruding cytosolic protons [44]. 
1.4.3. Systems for regulation of MTB metabolic and growth state in the granuloma 
MTB possesses at least three systems that regulate its metabolic and growth state in 
latent phase [16]. First, a well-characterized bacterial regulon that is controlled by 
DosR-DosS – a two-component system in mycobacteria – is induced by several 
stimuli, thought to play role in the latent TB, including local hypoxia [17, 18], nitric 
oxide [19] and carbon monoxide [20, 21]. This ‘dormancy’ regulon controls the 
expression of genes that allow the bacteria to use alternative energy sources, in 
particular lipids, and genes encoding factors that are selectively recognized by T 
cells from humans with latent TB. Second, MTB has a system of five proteins that 
resemble the well-characterized Micrococcus luteus  resuscitation-promoting factor 
(Rfp), which is a secreted protein that has the ability to ‘resuscitate’ bacteria from a 
nutrient-starved dormant state [22]. Deletion of one or more of MTB Rfp genes 
generates bacteria that have an impaired recovery from dormancy, indicating that 
these genes may participate in the progression from latency to reactivation [23, 24]. 
Finally, MTB encodes 88 toxin-antitoxin gene pairs, the expression balance of which 
regulates multiple phenomena, including whether the bacteria replicate or remain 
static [25]. 
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1.4.4. MTB defense mechanisms against oxidative and nitrosative stress 
Activated macrophages express two enzymes, phagocyte oxidase (NOX2) and 
inducible nitric oxide synthase (iNOS) which generate reactive oxygen intermediates 
(ROI) and reactive nitrogen intermediates (RNI) respectively [41]. Upon 
phagocytosis, the preformed NOX2 subunits assemble into an enzymatically active 
enzyme complex that transfers electrons across the membrane from cytosolic 
NADPH to molecular oxygen. As a result, superoxide anions are produced. They 
dismutate into hydrogen peroxide (H2O2) and generate toxic hydroxyl radicals [45]. 
iNOS is induced by IFNγ and produces nitrite and nitrate via nitric oxide. Under the 
acidic conditions of the phagosomes of IFNγ-activated macrophages, nitrite forms 
nitrous acid, which dismutates to nitric oxide (NO) and another toxic radical, nitrogen 
dioxide [46]. NO can synergize with superoxide (produced by macrophages or 
generated as a byproduct of respiratory metabolism by the pathogen) to form 
poisonous peroxynitrite [47]. These ROI and RNI can be bactericidal as they react 
with a wide variety of molecules, including nucleic acids, proteins, lipids and 
carbohydrates. To counteract such stress, MTB has a variety of molecules to either 
detoxify ROI and RNI before they can harm the bacteria or to repair damage which 
they caused. 
One such resistance mechanism is mediated by the katG product catalase-
peroxidase, which decomposes H2O2 into water and oxygen. MTB lacking katG 
exhibited no catalase activity and was hypersusceptible to H2O2 in culture [48]. 
MTB contains two genes encoding superoxide dismutases – enzymes catalyzing the 
conversion of superoxide anions to hydrogen peroxide – sodA and sodC. SodC is a 
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Cu,Zn superoxide dismutase localized to the mycobacterial cell envelope [49]. Lack 
of sodC increases susceptibility of MTB to superoxide, to the combination of 
superoxide and nitric oxide and to killing by IFNγ-activated murine macrophages 
[50]. In contrast, resting wild type macrophages did not kill the sodC mutant which 
suggests that Cu,Zn superoxide dismutase contributes to MTB’s resistance against 
oxidative burst products generated by activated macrophages. Its role during the 
long-term chronic infections has not been determined. SodA, which uses iron instead 
of Cu,Zn, may compensate for SodC to protect against the respiratory burst in 
resting macrophages and during mouse infections. SodA appears to be essential for 
in vitro growth [51]. MTB mutants with reduced sodA expression displayed increase 
susceptibility to H2O2 and were significantly attenuated in mice [52]. 
5’-adenosinephosphosulfate reductase CysH also has antioxidant activity as its 
mutant displayed increased susceptibility to H2O2 and peroxynitrite [53]. Decreased 
levels of downstream metabolic products including mycothiol could be the cause for 
this. 
To detoxify both RNI and ROI, MTB expresses an NADH-dependent peroxydase and 
peroxynitrite reductase that consists of four proteins: alkylhydroperoxide reductase 
subunit C (AhpC), a thioredoxin-related oxidoreductase (AhpD), dihydrolipoamide 
acyltransferase (DlaT) and lipoamide dehydrogenase (Lpd) [54, 55]. 
A novel MTB gene, noxR1, has been shown to confer resistance to the toxic effects 
of RNI, although the precise mechanism is not known. The noxR3 gene also 
protected bacteria from ROI and RNI [56].  
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The sulfur of cysteine and methionine residues in proteins is highly susceptible to 
oxidation and exposure of methionine to ROI and RNI leads to the generation of 
methionine sulfoxide, which can interfere with protein function. Methionine sulfoxide 
can be converted back to methionine by methionine sulfoxide reductase (Msr). Msr 
might also serve as a sink for oxidants before they damage cellular macromolecules. 
MTB expresses two Msr enzymes. When lacking both msrA and msrB, the bacteria 
was more readily killed by acidified nitrite, but the mutant was not hypersusceptible 
to H2O2 [41]. 
It has been also shown that mutations in the excision repair gene uvrB result in 
severe sensitivity to RNI [41].  
1.4.5. Difference between murine and human macrophages 
There is a controversy about the differences between rodent and human 
macrophages [56-58]. Some researchers have even suggested that human 
macrophages are “fundamentally” different from rodent macrophages [57]. The 
central problem of the controversy is the use of arginine for NO production. As 
mentioned above, in macrophages NO is produced by iNOS, an oxidoreductase that 
catalyzes the conversion of arginine and oxygen to NO and citrulline. The NOS2 
gene (encoding iNOS) is present in both rodents and humans. In mouse models of 
intracellular infection NO production by iNOS has been established as essential for 
effective immunity to MTB and several other bacterial species [58]. However, the role 
of NO in human macrophages is unexpectedly controversial. While in murine 
macrophages it has been shown that a significant amount of NO is produced, in 
human monocyte-macrophage cell lines no NO production has been identified. 
12 
 
 
 
Moreover, in direct opposition of the in vitro data, human tissues, such as TB biopsy 
samples, express abundant iNOS. What can be the reason for this discrepancy? 
Experiments in human macrophages to measure iNOS and NO are performed 
almost universally in cells derived from donor monocytes and are “differentiated” in 
vitro in media such as RPMI. There is no guarantee that such a system is permissive 
to iNOS expression. The simplest hypothesis is that the culture conditions and/or the 
cell type are lacking in one or more factors that allow iNOS expression in human 
macrophages in vitro [58]. 
A similar scenario exists for the arginases. There are two arginase enzymes: Arg1 
and the mitochondrial Arg2. In humans Arg1 appears to be expressed only in 
neutrophils, and mouse Arg1 is expressed in macrophages and neutrophils. Mouse 
Arg 2 is also expressed in macrophages and neutrophils [58].  
1.5. Modeling persistence in vitro 
The stationary phase culture is the simplest model of MTB persistence. The kinetics 
of replication of the bacteria in the lungs of mice are similar to the organism’s 
replication in culture where an initial period of exponential growth is followed by an 
extended period in which the number of viable bacilli remains stable. As a result, the 
stationary phase culture is a simple, inexpensive, and easily manipulated system to 
analyze the long-term survival of non-replicating cells of MTB. Important 
observations about MTB drug susceptibility and response were made using this type 
of culture [5]. 
A well-known in vitro model of dormancy was developed by Wayne [6, 59]. The 
system relies on a self-generated O2 gradient. In the model a sealed, standing 
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culture is allowed to incubate over a period of days while the bacteria deplete the 
available oxygen. The model demonstrated that MTB was capable to survive in 
anaerobic conditions (supposedly the conditions that the bacteria face in lesions) in 
vitro and the bacteria that survived anaerobiosis underwent stage-specific cell cycle 
arrest represented by two non-replicating persistence states. The dormant state 
induced by oxygen deprivation (hypoxia) was characterized by almost total shutdown 
of DNA, RNA and protein synthesis and relative resistance to antimycobacterial 
agents such as isoniazid. Thus, adaptations to hypoxia are thought to play a 
prominent role in MTB pathogenesis and latency. 
Despite improvements, the Wayne model still has the issue of reproducibility. A 
defined hypoxia model is an alternative in vitro model where the bacilli are exposed 
to defined hypoxic atmospheres that remain constant throughout the experiment. In 
this approach, oxygen tensions of 1% or less halt replication but bacteria remain 
viable [60]. A defined hypoxic model has been used to obtain the transcriptomics 
data which will be introduced in chapter 2. 
1.6. Signature genes involved in hypoxic response 
Wayne’s in vitro model of MTB latency has been used to demonstrate the 
upregulation of the glyoxylate cycle, a metabolic pathway that allows the bacteria to 
use acetate or fatty acids as the sole carbon source. The activity of a key enzyme of 
the cycle, isocitrate lyase (icl) has been shown to increase in long-term cultures of 
MTB [7], and the disruption of icl attenuated the ability of MTB to persist in a murine 
model of infection [8]. Activation of infected macrophages increased expression of 
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icl, and the icl mutant was attenuated for survival in activated but not resting 
macrophages. 
Nitrate reductase activity is greatly accelerated during the first nonreplicating state in 
Wayne’s model [4]. Although MTB contains genes for nitrite reductase, reduction of 
nitrite has not been demonstrated and ammonium ion does not inhibit the reduction 
of nitrate. Thus, nitrate reductase probably serves a mainly respiratory, rather than 
assimilatory function, providing maintenance energy during non-replicating 
persistence. Two loci represent the nitrate reductase activity in the bacteria. The first 
locus is narGHJI which was shown to have reductase activity [12]. The second locus 
is called narX which was shown to be upregulated during anaerobic conditions in 
BCG [13]. 
Another gene, alpha crystallin homologue - hspX, a chaperone protein, has been 
reported to be produced by M. tuberculosis only when the bacilli encounter hypoxic 
conditions or are exposed to nitric oxide but not to a variety of other stresses, 
including heat shock [11]. 
1.7. Transcriptional regulation in latent phase 
1.7.1. DosR 
DosR (Rv3133c) is a transcriptional regulator involved in the initial response to 
hypoxia [61, 64]. Phosphorylation of DosR by either of two sensor histidine kinases, 
DosS or DosT [62], leads to the induction of a set of ~50 genes, many of them with 
unknown function. Among the genes with known or predicted function there are 
several that may play a role in adaptation to hypoxic stress: acr (stabilizing partially 
denatured proteins); narX, narK2 and fdxA (nitrate accumulation and alternative 
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electron transport); nrdZ (dNTP synthesis under microaerophilic conditions); tgs1 
(triglyceride synthase) and six MTB orthologues of the universal stress protein family 
(resistance to DNA damage) [59]. It has been shown that the DosR-dependent 
regulon is also induced in response to nitric oxide [65], in macrophages [66], in both 
early [67] and late mouse infections [68], and in response to carbon monoxide [69], 
SDS [70] and low pH [71]. Non-replicating persistence in vitro and chronic infection in 
vivo occur despite disruption of the DosR regulon suggesting that rather than in 
dormancy response, the DosR regulon may play a much more important role in 
survival of extended respiratory, nitrosative or redox stress [59]. Transcriptional 
analysis under hypoxic conditions in vitro of an extended time course showed the 
existence of an additional so-called Enduring Hypoxic Response (EHR) comprising a 
set of 230 genes [63]. The number of transcription factors (TFs) in EHR regulon is 
higher than expected suggesting a complex regulatory circuit. These TFs include the 
iron uptake regulators FurA and FurB, three members of the WhiB family, the two-
component response sensor PhoP. Alternative sigma factors SigE and SigH are also 
induced during EHR [63]. 
1.7.2. KstR 
KstR (Rv3574) is a member of the TetR family of transcriptional regulators that 
controls the expression of a large regulon involved in lipid metabolism in 
mycobacteria [72]. There are 10 fad genes (fadA5, fadE26, fadE27, fadE28, fadE34, 
fadD8, fadD12, fadD17 and fadD19), one ech gene (echA19), one lip gene (lipO), 
and at least three ketoacyl-CoA thiolases (ltp2, ltp3 and ltp4). In addition, the mce4 
operon is part of this regulon, and it has been suggested that the mce operons are 
involved in the import of lipids or are lipid-associated [73]. Other genes in the KstR 
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regulon, hsaC and hsaD (formerly bphC and bphD respectively), have been 
implicated in both cell wall synthesis [74] and cholesterol degradation [73]. Later 
studies for these two genes and some others have confirmed a role in cholesterol 
catabolism [73]. A second TetR-type repressor, KstR2, controls the expression of a 
small regulon (15 genes) which may also play a role in cholesterol utilization in 
mycobacteria. KstR and KstR2 coordinately control more than 70 genes that are all 
de-repressed by growth on cholesterol [74]. 
1.7.3. PhoP 
PhoP (Rv0757) is a transcriptional regulator of the two-component system PhoPR 
[76-78]. Inactivation of phoP leads to high attenuation of MTB. However, it is not 
completely eliminated and persists in vitro cultured-macrophages and in mouse 
organs [79]. Further supporting the role of PhoP in virulence regulation, it has been 
shown that a point mutation in PhoP contributes to avirulence of the H37Ra strain, 
since this mutation disrupts secretion of the ESAT-6 antigen and the synthesis of 
acyltrehalose-based lipids in this strain [80-82]. Comparing both the transcriptome 
and the proteome of MTB wild type with a phoP mutant, another group has extended 
the regulatory network of PhoP and assigned it to several functional groups [77]. 
PhoP controls some of the genes of the DosR regulon including dosRS genes 
themselves. Alpha crystallin, a latency antigen, also appeared downregulated in the 
phoP mutant. Altogether, these observations indicate that PhoP might regulate 
partially the dormancy regulon through cross-talking to DosR. PhoP also regulates a 
subset of genes from EHR.  
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A second group of genes regulated by PhoP have respiratory functions. PhoP 
positively regulates nuo genes from the NADH dehydrogenase operon. This 
enzymatic complex functions as a primary electron acceptor via oxidation of NADH 
to NAD+. NuoG inhibits apoptosis in macrophages and increases virulence in 
immuno-compromised mice [83]. PhoP also regulates the expression of the enzyme 
alanine dehydrogenase (ald). This enzyme participates in maintaining the NADH 
pool by recycling NAD+ through the conversion of pyruvate to alanine when oxygen, 
as a terminal electron receptor, becomes limited [84]. Additionally, PhoP controls the 
genes involved in utilization of nitrogen and sulfur sources in oxygen limiting 
conditions such as the nitrite transporter narK1 and the sulfur reduction operon nirA-
cysH [85]. 
PhoP has been shown to positively regulate genes within the RD1 genomic region. 
The RD1 region is essential for MTB virulence and encodes the secretion system 
ESX-1 which assures export of the major T-cell antigen complex ESAT-6/CFP10 [86-
88]. Potential transcriptional mechanism for control of ESAT-6 secretion involves 
espB gene and the ESX-1 secreted protein regulator espR both of which are 
regulated by PhoP [77]. 
PhoP positively regulates genes implicated in MTB lipid metabolism. These genes 
include pks3, Rv1184c, fadD21 and pks2, involved in the synthesis of acyltrehalose-
based lipids [89], lipF coding for a lipid esterase required for virulence in mice [90], 
and fadD9 which encodes a hypothetical fatty acid-CoA ligase. Additionally, PhoP 
controls the fatty acids gene encoding a fatty acid synthase which together with the 
FAS II system generates precursors for the synthesis of mycolic acids. 
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All the functional groups regulated by PhoP are also differentially expressed in 
response to macrophage infection indicating that PhoP might control key functions 
for intracellular survival [77].   
PhoP has been shown to positively regulate the aprABC locus whose gene 
expression is induced during growth in acidic environments in vitro and in 
macrophages [78]. Deletion of this locus causes defects in gene expression that 
affect aggregation, intracellular growth, and the relative levels of storage and cell wall 
lipids. A model has been proposed where phoPR senses the acidic pH of the 
phagosome and induces aprABC expression to change the expression of the set of 
genes this locus regulates. Additionally, there is a positive feedback loop of aprABC 
on phoP which should enable rapid adaptation for the host environment [78].  
1.7.4. WhiB3 
WhiB3 (Rv3614) is a high-level redox regulator in MTB [91-93]. WhiB3 senses 
fluctuations in the intracellular environment associated with O2 depletion, including 
the metabolic switch to the favored in vivo alternative carbon source, fatty acids [92]. 
WhiB3 has been implicated in several metabolic functions. First, this TF is essential 
for maintaining bacterial shape and size [91, 92]. Second, WhiB3 regulates the 
anabolism of MTB complex virulence lipids such as polyacyltrehaloses (PAT), 
diacyltrehaloses (DAT), sulfolipids (SL-1), and phthiocerol dimycocerosates (PDIM), 
which involves the use of large quantities of reducing equivalents (NAD[P]H). Third, 
WhiB3 was shown to maintain redox homeostasis during infection of macrophages 
[92]. Fourth, the MTB ΔwhiB3 showed decreased production of PAT, DAT and SL-1, 
but increased production of PDIM, and to a lesser extent triacylglycerol (TAG) [92]. 
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MTB ΔwhiB3 accumulates PDIM and TAG during intramacrophage growth, 
suggesting that  this intermediate is channeled into PDIM via the methyl-malonyl 
CoA (MMCoA) pathway and into TAG as a result of the increased resistance to 
propionate toxicity [93]. As mentioned above, PhoP also regulates positively the 
production of PAT, DAT and SL-1 but the expression of phoP is not altered in MTB 
ΔwhiB3 [92] and MTB ΔphoP did not accumulate PDIM or TAG. Thus, the WhiB3-
dependent control of cellular redox homeostasis may be an additional factor that is 
required to regulate the flux of propionyl CoA to methyl-branched polyketides and 
TAG synthesis. 
WhiB3 was shown to bind to the upstream sequence of lipid biosynthesis genes pks2 
and pks3 [92, 93].  
1.7.5. Sigma factors 
MTB encodes a repertoire of 13 σ factors [94]. SigA is indispensable for growth in 
MTB. The sigA transcript is maintained at a constant level under various stress 
conditions. For that reason sigA continues to be widely used as an internal standard 
for normalization in quantitative RT-PCR experiments. A point mutation in one of the 
domains of SigA resulted in attenuation of virulence of M. bovis strain ATCC 35721 
in a guinea pig model of infection. Overexpression of sigA in MTB H37Rv enhanced 
its growth in human macrophages and in the lungs of mice after aerosol infection, 
which further suggests its role in virulence [94]. 
SigB has been found to be dispensable for growth in M. smegmatis and MTB. The 
expression of sigB increases upon exposure to different environmental stresses such 
as low aeration, treatment with hydrogen peroxide and heat shock. The inactivation 
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of the sigB gene does not affect the survival of MTB during infection in human 
macrophages or in mouse and guinea pig models. However, deletion of sigB in MTB 
results in its higher sensitivity to SDS-induced surface stress, heat shock, oxidative 
stress, exposure to vancomycin and hypoxic conditions. Overexpression of sigB 
resulted in upregulation of genes encoding proteins involved in cell wall-related 
processes, ESAT-6-like proteins, 50S ribosomal proteins, PE-PGRS proteins, keto-
acyl synthase, KasA and the TFs WhiB2, IdeR and SigB itself. Expression profiling of 
MTB sigB mutant showed regulation of ideR, furA, katG, ppe19 and hsp20 by SigB 
[94]. 
SigC is downregulated during stationary phase and in reponse to heat shock and 
SDS-induced surface stress [94]. SigC is not required for the survival of MTB in 
murine bone marrow-derived macrophages. In a mouse model of infection, sigC 
mutant in both CDC1551 and RV37Rv backgrounds grows and persists in lungs but 
shows attenuated disease progression.  The attenuation of sigC mutant may result 
from dysregulation of expression of several key virulence-associated genes, such as 
hspX, senX3, mtrA, polyketide synthases and fbpC (antigen 85C). 
SigD is expressed at a moderately high and constitutive level during exponential and 
stationary growth phases and declines significantly, following hypoxia, a pattern very 
similar to that of SigA in an in vitro culture. This response is modulated by the relA 
gene product via the synthesis of a key signaling molecule, guanidine tetraphosphate 
(ppGpp). RelA deletion in MTB results in a loss of virulence accompanied with a 
significant decrease in sigD expression during logarithmic phase, sigD is upregulated 
during nutrient starvation, further suggesting the role of SigD in physiological 
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adaptations and starvation. Some of the important genes regulated by SigD include 
those encoding proteins involved in lipid metabolism, cell wall-related processes, 
stress response and DNA binding and repair. Several genes, such as rpfC 
(implicated in the revival of dormant bacteria), pks10 (polyketide-like chalcone 
synthase), recR and those encoding several chaperones, ribosomal proteins, 
elongation factors and ATP synthase subunits were also reported to be 
downregulated in the MTB sigD mutant [94]. 
SigE is upregulated in mycobacteria grown in human macrophages compared with 
those grown in an in vitro culture. Its expression also increases under exposure to 
heat shock, SDS-mediated surface stress, isoniazid and vancomycin [94]. The MTB 
sigE mutant showed decreased viability in macrophages. SigE-dependent genes 
encode proteins that belong to different classes such as TFs (including SigB, 
Rv3050c, MprA and MprB), enzymes involved in fatty acid metabolism (most 
importantly icl) and the classical heat shock proteins [94]. 
MTB H37Rv sigF was found to be upregulated in a nutrient starvation model of MTB 
and during infection of cultured human macrophages. However, it was shown that 
SigF is not required for MTB survival under nutrient starvation conditions and within 
activated murine macrophages or for extracellular persistence in an in vivo 
granuloma model of latent TB infection [94]. SigF regulates the expression of genes 
involved in the biosynthesis and structure of the mycobacterial cell envelope, 
including complex polysaccharides and lipids, particularly virulence-related 
sulfolipids. SigF also regulates a number of TFs including PhoY1 and Rv2884 as well 
as SigC. Conditional overexpression of sigF during the early exponential phase 
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resulted in upregulation of several genes encoding PE and PPE family proteins and 
mmpL family transporters known to be involved in virulence. 
sigG is one of the most highly induced genes in MTB during macrophage infection, 
and has been shown to be required for the survival of the bacteria. However, its 
expression is downregulated upon exposure to various stress conditions, such as 
mild shock, heat shock, low aeration and SDS-mediated surface stress. The sigG 
mutant strain showed downregulation of several genes encoding proteins involved in 
fatty acid metabolism such as AceA (isocitrate lyase), FadE5 (acyl-coenzyme A 
dehydrogenase) and ScoA (succinyl-coenzyme A) [94].  
SigH is a central regulator of oxidative and heat stress responses in MTB. Although 
the expression of sigH was found to be induced during macrophage infection, the 
sigH mutant was not attenuated for growth in human macrophages. The SigH 
regulon includes its own structural gene and genes encoding SigB, SigE, Rv0142 
(putative transcriptional regulator), DnaK, ClpB (heat shock proteins), TrxB and TrxC 
(thioredoxin reductase/thioredoxin). SigH also induces enzymes involved in cysteine 
biosynthesis and in the metabolism of ribose and glucose [94].   
Unlike sigE and sigH, sigL does not play a role in oxidative and nitrosative stress 
responses. Its regulon includes genes involved in lipid biosynthesis (pks7, pks10, 
ppsA), fatty acid transport (mmpL13a, mmpL13b), sigB [94]. 
Overexpression of SigM revealed upregulation of four putative esat-6 homologs 
(esxT, esxU, esxE and esxF). Positive regulation of Esx family secretory proteins by 
SigM suggests its role in long-term adaptation to specific host environments. Other 
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genes identified to be regulated by SigM include PPE family members (ppe1, ppe19, 
ppe60), fatty acids, pks2 and pks3, genes from the first operon of PDIM biosynthetic 
and transport locus, mas gene, kasA-kasB operon, required for mycolic acid 
synthesis [94].   
1.8. Lipid metabolism 
The metabolism of host lipids and the production of cell wall lipids are central for the 
survival of intracellular MTB. There is growing body of evidence supporting the fact 
that  the bacterium is able to utilize host lipids, such as fatty acids and cholesterol, to 
persist within the host cell. Host lipids appear to be the primary carbon source for 
MTB in vivo or in infected macrophages. MTB was shown to have the incredible 
ability to simultaneously co-catabolize multiple carbon substrates [99]. Moreover, 
during co-catabolism, the bacterium catabolizes each carbon source differentially 
through the glycolitic, pentose phosphate and/or tricarboxylic acid pathways to 
distinct metabolic fates. In total, the lipid metabolic machinery of MTB consists of 
about 250 distinct enzymes compared to only 50 in E. coli [95]. 
1.8.1. Cholesterol metabolism 
Cholesterol is known to be one of the main host lipids that are required for the growth 
and persistence of MTB in mice [104], and mutants defective in either uptake or 
processing of cholesterol exhibit severe defects in intracellular growth and survival 
[105-107, 110-111].  Studies have shown that cholesterol is essential for the uptake 
of mycobacteria by macrophages, and it has been found to accumulate at the site TB 
entry and mediate the phagosomal association of TACO, a coat protein that prevents 
degradation of mycobacteria in lysosomes [106]. Bioinformatic analysis in 
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Rhodococcus sp. [108] and subsequent more recent mutagenesis studies in MTB 
[111] identified 83 genes that are essential for MTB growth in vitro and cholesterol 
catabolism. These genes are categorized in three functional groups associated with 
cholesterol utilization: (1) steroid ring degradation, (2) side-chain degradation, and 
(3) intermediary metabolism [112]. Cholesterol has been shown to be utilized via 
androstenedione/androstadienedione pathway and this process requires production 
of an intact KstD enzyme [110]. The growth of MTB on cholesterol was significantly 
affected by a knockout of the mce4 gene, which encodes an ABC transporter 
responsible for cholesterol uptake [104]. Another locus, igr, which was previously 
found to be essential for intracellular growth and virulence of MTB, is required for 
cholesterol metabolism: igr-deficient bacteria cannot grow using cholesterol as a 
primary carbon source [105]. Recently, it has been demonstrated that growth on 
cholesterol requires the transcriptional induction of the propionyl-CoA-assimilating 
methylcitrate cycle enzymes via the Rv1129c regulatory protein [109]. Additionally, 
FadD3, regulated by Kstr2, was shown to be an acyl-CoA synthetase that initiates 
catabolism of cholesterol rings C and D [113], and FadA5 was found to be a thiolase 
required for virulence and production of androstenedione and androstadienedione 
[113]. 
1.8.2. Fatty acid metabolism 
Fatty acids are the other carbon source utilized by MTB during infection. Evidence 
dates back to Bloch and Segal [100], who reported the preferential utilization of fatty 
acids as carbon source by MTB in the lungs of infected mice. When the MTB 
genome was sequenced, another group [95] showed the relative 
“overrepresentation” of genes predicted to be involved in the processing and 
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degradation of fatty acids. Additionally, genes involved in routing the products of fatty 
acid degradation through pathways such as the glyoxylate shunt and 
gluconeogenesis significantly influence the bacterium’s phenotype in a range of 
different infection models [8, 100-103]. The genes encoding fatty acid β-oxidation 
enzymes together with those of the glyoxalate cycle are shown to be up-regulated 
during infection in macrophages [66] and mice [96-97]. The source and types of fatty 
acids that might be utilized by MTB during infection are still unknown. One possible 
source is the complex long-chain fatty acids such as dipalmitoyl phosphatidylcholine, 
present in the lung surfactant, which the bacteria can metabolize in a glyoxalate 
cycle-dependent manner [98]. Fatty acids can be also derived by hydrolysis of lipids 
in the phagosomal membrane. 
1.8.3. Mycolic acid metabolism 
Mycolic acids are very long-chain fatty acids representing essential components of 
the mycobacterial cell wall [114]. They are found, primarily, as building blocks of 
arabinogalactan but also present as extractable “free” lipids within the cell wall, 
mainly associated to trehalose to form trehalose dimycolates (TDM). TDMs are the 
most abundant and significant toxic lipid extractable from the cell surface of virulent 
MTB. Mycolic acids provide MTB with resistance to chemical injury, resistance to 
dehydratation, low permeability to hydrophobic antibiotics, virulence and the ability to 
persist within the host. In addition, the enzymes involved in mycolate biosynthesis 
are essential for survival of the bacterium within the host. Free mycolic acids were 
observed to increase during hypoxia and be reversed in re-aeration, while opposite 
effects were found for trehalose monomycolates (TMMs) and TDMs [159]. 
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The biosynthetic pathway of mycolates involves two types of fatty acid-synthesizing 
systems, the type I and type II fatty acid synthases, FAS-I and FAS-II, respectively. 
FAS-I catalyses the de novo synthesis of fatty acids from acetyl-CoA. FAS-II is 
composed of four dissociable enzymes that act subsequently and repeatedly to 
elongate the growing acyl chain. The biosynthetic process involves five stages: (1) 
the synthesis of the C26 saturated straight chain fatty acids by FAS-I to provide the α-
alkyl branch of the mycolic acids, (2) the synthesis of the C56 fatty acids by FAS-II to 
provide the meromycolate backbone, (3) the introduction of functional groups to the 
meromycolate chain by numerous cyclopropane synthases, (4) the condensation 
reaction catalyzed by the polyketide synthase Pks13 between the α-branch and the 
meromycolate chain before a final reduction to generate the mycolic acid and (5) the 
transfer of mycolic acids to arabinogalactan and other acceptors such as trehalose 
via the Antigen 85 complex. 
The MTB fas gene (Rv2524c) encodes the multifunctional FAS-I polypeptide that 
contains all the functional domains required for de novo fatty acid synthesis. All 
intermediates generated remain enzyme-bound during the process of elongation and 
undergo transacylation to other catalytic sites within the enzyme. FAS-I generates 
short-chain fatty acyl-CoA primers that are further elongated by FAS-II. 
Several enzymes are involved in the elongation process of FAS-II. MtFabH is the 
initiator of mycolic acid elongation and it catalyzes the condensation reaction of Acyl-
CoA primers with malonyl-AcpM. MabA, FabG1 and InhA catalyze the next step of 
keto-reduction, dehydration and enoyl-reduction of the acyl-CoA AcpM precursor. 
KasA and KasB are two β-ketoacyl-AcpM synthases that catalyze the initiation of 
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subsequent rounds of acyl extension by FAS-II. KasA is suggested to catalyze the 
initial elongation reactions while KasB extends the elongation to full-length 
mycolates. KasB was found to be essential for MTB virulence.The final step in the 
synthesis of mycolic acids in MTB is the condensation of C26-S-CoA and 
meromycolyl-AMP. Pks13 (Rv3800), a member of the type I polyketide synthase 
family,  has been shown to participate in this final step in mycolate assembly has 
been demonstrated. A specific fatty acyl-AMP ligase (FadD32) converts each 
meromycolyl-S-AcpM derived from the FAS-II system to meromycolyl-AMP Following 
release from FAS-I, the C26-S-CoA is carboxylated by the acyl-CoA carboxylases 
AccD4 and AccD5 to yield 2-carboxyl-C26-CoA. 
1.8.4. TAG accumulation and catabolism 
Fatty acids are normally stored as TAG in the adipose tissues of mammals, seed oils 
of plants and as lipid inclusion bodies in prokaryotes for use as energy source during 
and after dormancy/ hibernation. Based on that observation, TAG was postulated to 
be the storage form of energy for latent MTB [115]. Intracellular lipid inclusion bodies 
were initially observed in MTB more than fifty years ago and were more recently 
detected in mycobacteria isolated from the sputum of TB patients [116]. TAG 
accumulation was shown to be a critical event of MTB dormancy [117]. 
Triacylglycerol synthase 1 (Tgs1) was discovered to be the primary contributor to 
TAG synthesis within MTB and the deletion of tgs1 led to a nearly complete loss in 
TAG accumulation by MTB under in vitro dormancy-inducing conditions [118]. The 
source of fatty acids for synthesis of the TAG that accumulates as lipid droplets in 
the pathogen remains unknown. The lipid-loaded foamy macrophages which are 
found inside the hypoxic environment of the TB granuloma contain abundant stores 
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of TAG and are thought to provide a lipid-rich microenvironment for MTB. Human 
macrophages cultured under hypoxia (1% O2) accumulate TAG in lipid droplets 
[119]. 
Recently a group has demonstrated that MTB imports fatty acids released from host 
TAG to accumulate TAG within the bacterial cell [115]. Host fatty acids were 
incorporated intact into MTB TAG. They also show that host TAG is imported by 
MTB and accumulate as lipid droplets within the bacterial cell. Deletion of tgs1 
resulted in a drastic decrease of TAG accumulation within MTB inside macrophages 
suggesting that synthesis of TAG within the pathogen from fatty acids released from 
host TAG constitutes the major pathway of TAG accumulation by the pathogen 
inside the host [115]. The accumulation of TAGs as well as high expression of tgs1 
was also observed during hypoxia [159]. 
1.8.5. Complex lipid metabolism (SL-1, PAT/DAT, PDIM) 
MTB possesses a complex cell wall that contributes to its pathogenesis and 
resistance to therapeutics. The cell wall is represented by multiple layers exterior to 
the cytoplasmic membrane and consists not only of peptidoglycan but also 
arabinogalactan polysaccharide layers and an extremely hydrophobic bilayers known 
as the mycobacterial outer membrane [120, 122] (Fig. 1). The base of the 
mycobacterial cell wall is the plasma membrane which anchors the principal 
liposaccarides, lipomannan and lipoarabinomannan through phosphatidyl inositol 
mannosides. The plasma membrane also interacts with a peptidoglycan layer which 
is connected to the arabinogalactan through phosphodiester linkages. This assembly 
forms the core of the mycobacterial cell wall, on which various complex lipids are 
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tethered. Mycolic acids are esterified to the arabinose sugar to form mycolyl 
arabinogalactan. As mentioned above, mycolic acids are also acylated to trehalose 
units to form TMMs  and TDMs. Other lipids such as sulfolipids (SL), polyacyl 
trehaloses (PAT), diacyl trehaloses (DAT), phthiocerol dimycocerosate (PDIM) and 
mannosyl-β-1-phosphomycoketides interact intensively with mycolyl arabinogalactan 
and are sometimes shed out of the cell wall [122]. 
1.8.5.1. SL-1 
SL-1 has been implicated in the inhibition of mitochondrial oxidative phosphorylation, 
alteration of phagosome-lysosome fusion, and stimulation as well as suppression of 
cytokine and reactive oxygen species production in host leukocytes [120, 122]. 
However, MTB gene disruption strains lacking fully synthetized SL-1 do not appear 
to have phenotypes distinguishable from wild type MTB in animal models of infection. 
In contrast, the diacyl sulfolipid SL1278, a biosynthetic precursor of SL-1, is a well 
documented active metabolite which was shown to induce an immune response 
[122]. 
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Figure 1. Mycobacterial cell wall envelope depicting some of the essential methyl-
branched lipids. MPM - mannosyl-β-1-phosphomycoketide. Figure adapted from Gokhale 
RS et al., Nat. Prod. Rep., 2007. 
 
The sulfotransferase Stf0 initiates SL-1 biosynthesis by sulfating the abundant 
disaccharide trehalose to form T2S. The acyltransferase PapA2 then catalyzes the 
esterification of T2S to generate a monoacylated intermediate, SL659. The 
polyketide synthase Pks2 synthesizes methyl-branched (hydroxy)phthioceranoyl 
chains using an activated fatty acid starter unit provided by the fatty acid AMP ligase 
FadD23. PapA1 transfers the product of Pks2 to SL659, yielding diacylated SL1278. 
Additional acylations of SL1278 are required to produce fully elaborated SL-1. These 
final steps are chemically similar to the reaction catalyzed by PapA1, but there is no 
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in vitro evidence that PapA1 is capable of this activity. The lipid transporter MmpL8 
has been implicated in SL-1 formation. The MTB ΔmmpL8 gene disruption mutant 
accumulates the diacyl precursor SL1278 in the cell membrane rather than the 
predicted SL-1, implying that MmpL8 is required for biosynthesis as well as transport. 
It was also demonstrated that the final steps in SL-1 biosynthesis and SL-1 transport 
require Sap (Rv3821) and Chp1 (Rv3822) in addition to MmpL8 [122]. Interestingly, 
a stf0-deletion mutant was shown to exhibit augmented survival in human but not 
murine macrophages, suggesting that SL-1 negatively regulates the intracellular 
growth in species-specific manner [121].  
1.8.5.2. PAT/DAT 
Mycolipenic acids, the major acyl substituents found in PAT and some forms of DAT, 
have been shown to be potent inhibitors of leukocyte migration in vitro [123-124]. As 
well as being B-cells antigens, DAT also inhibit proliferation of murine T cells in vitro. 
It was also shown that the deficiency of PAT/DAT and PAT affects the surface global 
composition of mycobacterial cell envelope improving the efficiency with which MTB 
binds to and enters phagocytic and non-phagocytic host cells [124]. 
 Pks3 and Pks4 are the only enzymes involved in the synthesis of PAT/DAT that 
have been characterized so far. The targeted disruption of pks3-pks4 resulted in 
mutants lacking PAT/DAT [123]. PapA3 has been demonstrated to be an 
acyltransferase required for PAT/DAT biosynthesis [160]. 
1.8.5.3. PDIM 
PDIM were found to be required for the multiplication of MTB during the acute phase 
of infection [123]. The presence of PDIM in the outermost layers of the envelope was 
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shown to protect MTB from cidal activity of the reactive nitrogen intermediates 
produced by activated macrophages. The presence of PDIM also results in down-
regulation of the secretion of pro-inflammatory cytokines TNFα by murine 
macrophages and dendritic cells [123]. 
Methylated fatty acids of PDIM are sythetized by a multifunctional protein, 
mycocerosic acid synthase (Mas). The first step in the biosynthesis of phthiocerol 
involves the transfer of a long-chain fatty acid on protein PpsA by FadD26. Once this 
starter unit is loaded at the active cysteine residue of the ketosynthase domain and 
the acyl transferase domain transfers a malonyl group onto the phosphopantetheine 
arm of the acyl carrier protein domain, a decarboxylative condensation occurs that 
extends the long-chain fatty acid by a two-carbon unit. This chain is then covalently 
transferred from the acyl carrier protein of PpsA to the active site KS domain of PpsB 
through an acyl transfer reaction. The PpsB protein again utilizes another molecule 
of malonyl-CoA to add a two-carbon unit and generates another hydroxyl group. 
Similar rounds of chain transfer and extension continue with PpsC and PpsD 
proteins, which convert the b-keto groups into completely saturated carbons due to 
the presence of additional dehydratase and enoyl reductase domains. The AT 
domain of the PpsE protein has broad substrate specificity and can therefore utilize 
both malonyl- as well as methylmalonyl-CoA extender units, which produces diversity 
in PDIMs.  The assembly and transport of PDIMs require several other proteins. 
Transesterification of mycocerosic acids with the diol component of phthiocerol is 
brought about by PapA5. The methoxy group at the 3-position of phthiocerol derives 
from reduction of a keto group by a stand-alone ketoreductase protein, which is 
followed by transfer of the methyl group by an Omethyl transferase protein Mtf2. The 
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mechanism of release of the phthiocerol chain from PpsE is presently unknown. The 
TesA protein from the Pps cluster is proposed to specifically interact with the PpsE 
protein to release the covalently acylated phthiocerol chain. The transmembrane 
protein MmpL7 is proposed to couple the synthesis of PDIM with its export outside 
the cell envelope, by specifically interacting with PpsE. Recently, it was found that 
the LppX protein was required for the translocation of PDIM across the plasma 
membrane [122]. 
1.9. Project overview 
As still not much information is available on the transcriptional regulation of MTB 
adaptations during latent phase, and on the regulation of changes in lipid metabolism 
in particular, the goal of this project was to identify the key regulators and regulatory 
programs responsible for the gene expression in hypoxia/re-aeration conditions and 
in macrophages. This dissertation describes work performed in support of a larger 
scale Tuberculosis Systems Biology Project with a focus on the use of ChIP-seq and 
expression data to reconstruct transcriptional regulation of lipid metabolism in MTB. 
The project is split into two major aims, each of which is described in one of the 
subsequent chapters. In Chapter 2 the identification of key regulators and regulatory 
programs underlying gene expression in MTB during hypoxia and re-aeration is 
described. Chapter 3 describes the regulatory programs identified in macrophage 
expression models and their comparison with the regulatory programs in the hypoxia 
model presented in Chapter 2. The final chapter summarizes the findings described 
in this work, and suggests potential experiments to follow up on these findings. 
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Chapter 2. Identification of regulators and regulatory programs underlying 
gene expression during hypoxia and re-aeration 
2.1. Introduction 
Although some of the metabolic adaptations of MTB to the host environment are 
known, the mechanisms underlying these adaptations are poorly understood. The 
only well-studied regulon involved in the expression changes during hypoxic 
conditions is DosR. Thus, the first goal of this project was to identify other key 
regulators and regulatory programs controlling metabolic adaptations to hypoxia, 
specifically the ones responsible for lipid metabolism.  
2.2. Prediction of regulatory networks 
The reconstruction of transcriptional networks from high-throughput data can provide 
valuable information about the regulation of gene expression in cells and cellular 
processes in general. The number of computational methods that are being 
developed to reconstruct transcription-regulatory networks (TRNs) is constantly 
increasing. The main available methods for general TRN inference methods as well 
as methods for dynamic TRN predictions will be described. Focus will be put on the 
DREM algorithm as the method chosen for the analysis in this project.  
2.2.1. General network inference methods 
The large number of possible solutions (the large search space) and the restricted 
number of independent data points turns TRN and module interference into a 
undetermined problem. To make the problem of underdetermination more tractable, 
module and network inference methods apply different strategies to reduce the 
search space and/or extend the amount of independent information. 
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2.2.1.1. Module-based versus direct network inference methods 
Genes belonging to the same module behave in a similar way under certain 
environmental conditions. Identification of gene modules involves methods that rely 
on clustering or biclustering (combining the selection of co-expressed gene sets with 
a condition selection step to infer the set of conditions that is relevant to the clustered 
genes). Module-based network inference procedures assign a regulatory program to 
these modules which drastically lowers the number of interactions to be evaluated 
during the inference process. Direct network inference methods assign an individual 
regulatory program to each single gene. A well-known example of a direct method is 
CLR, an expression-based network inference method that reconstructs an interaction 
between a TF and a target gene based on the mutual information in their expression 
[137]. Most module-based approaches not only predict regulatory interactions, but 
also identify the experimental conditions under which the predicted interactions take 
place. These methods can assign regulators with expression profiles that are less 
similar to those of their target genes unlike direct methods. On the other hand, direct 
methods cover interactions for a larger range of regulators, as module-based 
inference methods lose interactions with target genes that are not co-expressed with 
a sufficient number of other target genes [135]. 
2.2.1.2. Modeling combinatorial regulation 
Some methods simplify the problem of modeling combinatorial regulation by 
assigning regulators to their target genes one by one and composing the 
combinatorial regulatory programs in a post-processing step that finds sets of 
regulators which control the same target genes. This stepwise approach makes it 
impossible to differentiate between truly complex combinatorial regulation, in which 
36 
 
 
 
multiple TFs are integrated to trigger the observed gene expression pattern, and 
condition-dependent regulation, in which different TFs act independently to mediate 
expression of their target genes under different subsets of conditions. Other methods 
automatically take into account the condition dependency of the inferred 
transcriptional programs: regulators that are assigned to the same genes under 
different subsets of conditions are assumed to act independently, and the ones that 
are predicted to regulate the same group of target genes in similar conditions, are 
presumed to act combinatorially, as they are needed simultaneously to trigger the 
observed co-expression response. Some of these methods can also infer the mode 
of the combinatorial interactions between the assigned regulators (AND, OR, XOR 
relationships). 
2.2.1.3. Integrative versus expression-based methods 
Most non-integrative methods extract the information about regulator-target 
interaction relying only on expression data itself, assuming that the expression profile 
of the regulator is an indicator of its activity. This assumption disregards the 
important role of regulation mechanisms acting on levels other than transcription and 
the predicted interactions are restricted to cases when regulators are either co-
expressed or inversely correlated with their targets. Moreover, most expression-
based inference methods cannot distinguish between regulators that actually 
regulate a gene (i.e. has a direct causal effect) and regulators that are simply co-
expressed with a gene. Integrative network inference methods can extend the scope 
of their predictions beyond interactions that can be inferred from co-expression 
behavior and usually make more reliable predictions by complementing gene 
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expression with additional transcriptional information such as motif data or DNA-
protein interaction data. 
2.2.1.4. Global versus query-driven inference methods 
Global module inference methods search for the modules that explain most of the 
data. This usually involves identifying large pathways that consist of many genes and 
that are usually responsible for the general responses to major metabolic or 
condition shifts. Global approaches provide a general view of the active TRN. Query-
driven module detection methods, on the other hand, search for genes that are co-
expressed, in a condition-dependent way, with a predefined set of genes. These 
algorithms are deliberately biased towards finding a specific local solution in the 
search space based on a gene sets chosen specified by the user.  
2.2.2. Network prediction methods for time series data sets  
The transcriptional response to stresses is a dynamic process involving many TFs 
that can act at a different time. So just identifying the type of interactions between the 
TF and the regulated gene doesn’t give us information about the temporal control of 
the regulatory programs. The availability of time series data sets allows the 
reconstruction of dynamic regulatory networks which give us valuable information 
about the behavior of the networks over time and in response to different internal and 
external stimuli. Several types of methods have been developed specifically for the 
analysis of temporal data sets. 
2.2.2.1. Clustering methods 
To obtain a global view of the behavior of genes in time series experiment it is useful 
to divide (cluster) these genes into smaller groups based on their temporal 
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expression patterns. Several methods have been developed for clustering of time 
series data.  
One group of methods uses continuous representation of gene expression. Gene 
expression level can be represented by splines (piecewise polynomials with bounded 
constraints), piece-wise linear, quadratic, or higher-order interpolation [135]. One 
example is the method proposed by Bar-Joseph et al. [138] which uses B-splines. 
The clustering method assumes a mixture model where each mixture component 
corresponds to a cluster, and the expression of each gene is generated through a 
noisy process from the model expression curve. Bar-Joseph et al. describe a method 
that simultaneously estimates the parameters for the continuous representation and 
the assignment of genes to clusters [138]. 
The second type of methods perform clustering using dynamic features reflecting 
temporal patterns which are extracted from expression time series. Kim and Kim 
[139] use first- and second-order differences between adjacent time points as 
temporal features. Genes are clustered based on the pattern determined by the 
sequence of features. One limitation of the method is that it requires several replicate 
experiments and most time series expression data sets are measured with very few 
or no replicates. Déjean et al. [140] represent genes by smoothing splines, and use 
the derivatives at some discretization points as features. Genes are clustered by 
applying hierarchical clustering to the extracted derivatives.  
Another group of methods clusters genes using Hidden Markov Models (HMMs). 
Schliep et al. [141] developed a HMM method to model the dependency between 
observations of adjacent time points. An HMM is specified by a set of hidden states, 
39 
 
 
 
the probability of starting at a given state, the probability of transition from one state 
to the other, and the probability of generating the gene expression level at each 
state. The clustering is modeled by a mixture of HMMs, where each HMM 
corresponds to a cluster. Gene assignment and model parameters are estimated by 
maximizing the likelihood of the observed expression time series using an 
Expectation Maximization (EM) style algorithm. The number of clusters is determined 
by a heuristic procedure that removes clusters with too few genes and splits clusters 
with too many genes. In [141], a gene is assigned to the cluster corresponding to the 
most probable HMM.  HMM-based methods require that the number of time points to 
be much larger than the number of states and that is why they work well for long time 
series but may be problematic to use for short time series. 
Clustering of time series data can also be performed by using an autoregressive 
model [142]. An autoregressive model of order p assumes the expression level at a 
given time point is a linear function of the expression levels of the same gene in the 
previous p time points. The clustering algorithm uses an agglomerative procedure to 
search for the most probable set of clusters. It starts by assuming every expression 
time series is generated by a different process. In the next step, it computes the 
model likelihood for all possible pair-wise merges. The method then identifies the 
merge that results in the highest model likelihood, and, if it is higher than the current 
model likelihood, merges the two clusters. The procedure stops when the model 
likelihood cannot be improved by merging anymore. 
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2.2.2.2. Regression methods for causal inference 
Lagged correlations [143] can be used to search for regulatory relationships in time 
series data. The methods that use this approach can be divided into those that can 
be applied to a single data set and those that can be applied to multiple data sets at 
once. 
Most of the work applied to a single data set involves regression analysis to identify 
causal genes. Qian et al. [144] were among the first to use time series data for 
inferring interactions among genes. To identify causal relationships between a pair of 
genes they have used local alignment algorithms to find cases where a later 
expression of one gene matches an earlier expression of another gene and link 
these two genes. They have also analyzed inverted relationships that could identify 
repression effects.  
Another direction for determining causal relationships from time series data is the 
use of various graph theory-based methods also known as graphical models. These 
models include Bayesian networks [145] that have been successfully applied to 
study static expression data. An extension of Bayesian networks, Dynamic Bayesian 
Networks (DBNs) can be used to determine regulatory relationships from time series 
data, often improving on the static version for this type of data [146]. The major 
challenge associated with learning such networks from data is the condition that a 
large number of parameters needs to be estimated from a relatively small number of 
data points (time series experiments are often no longer than 8 time points). 
Combining multiple time series data sets when learning DBNs  or other time lag 
models may help in overcoming the dimensionality problem. However, combining 
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multiple data sets is a non-trivial problem as well. First, sampling rates differ between 
different data sets, making it hard to determine a common temporal unit for DBNs. 
Second, for a specific interaction pair (a TF and its target gene) the actual time lag 
may differ between different experiments since the time scale of the series data may 
change. Finally, even for a pair of genes displaying time lagged regulation, this 
relationship might exist in only a subset of the data sets since different pathways 
may be activated under different conditions. A possible way to combine multiple data 
sets is to ignore the time lag and rely instead on correlation between the profiles of 
genes in the data set. This effectively assumes a time lag of 0 for all pairs. For 
example, Lee et al. [147] used the correlation method to combine a large number of 
human expression data sets to search for correlated pairs. Another way to address 
this issue, which is appropriate for combining experiments that study the same 
system under different conditions (for example, different cell cycle arrest methods) is 
to align the data sets assuming that genes behave in the same way in all 
experiments though with different time units. The alignment process determines the 
appropriate transformation from one time series to another. Once the alignment is 
determined, the different data sets can be transformed into a common temporal 
representation and they can then be used to infer DBNs and other lagged models as 
discussed above.  However, when combining more diverse experiments (for 
example, cell cycle and stress experiments), such an assumption cannot be 
expected to hold anymore. Thus, DBNs have so far been limited to modeling 
individual data sets or similar data sets for the same biological system. Shi et al. 
[148] presented method that may overcome this problem and allow researchers to 
combine experiments from different conditions in a single DBN. These authors 
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presented an algorithm that uses a set of known interacting pairs to compute a 
temporal transformation between every two data sets, regardless of the condition 
they study. The underlying idea is that some interactions would be present in both 
data sets and these can be used to learn the temporal transformation between the 
two data sets. Using an EM algorithm, they align all time series data sets to a 
common reference data set (usually the longest) and use the aligned experiments to 
search for additional regulatory interactions, not used in the learning phase, that are 
present in multiple data sets.  
2.2.2.3. Integrative methods 
As discussed in the previous section, network inference methods that rely solely on 
time series gene expression data often face the problem of the number of 
parameters to fit being much higher than the number of time points. To overcome 
this problem to a certain extent, inference algorithms can incorporate other data 
sources to impose additional constraints and reduce the number of feasible models. 
Adding new types of data to existing models gives rise to its own set of challenges. 
Such information can be used in a pre- and/or post-processing step to eliminate 
inconsistent networks or can be tightly coupled with the network inference algorithm, 
which may require a fundamentally different computational framework. Furthermore, 
not all types of data are prevalent in certain species. For instance, whereas 
sequence data are readily available for many species of interest, genome-wide 
protein–DNA binding studies have only been performed for a few species. In 
addition, as noted earlier, sequence data are inherently static and protein–DNA 
binding, protein–protein interactions, and miRNA–mRNA interactions are generally 
measured at a single time point in a single condition. Thus, it is not always 
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straightforward to use this information to provide additional insight into dynamic 
regulatory processes. 
Kundaje et al. [149] combined time series gene expression profiles and occurrence 
counts of known motifs to learn transcriptional modules. Splines were used to model 
the dynamic expression data, and the modules were learned by using EM to optimize 
a generative probabilistic graph model. Ramsey et al. [150] extended the time-lagged 
correlation method to include a motif scanning step. Differentially expressed genes 
were clustered, a time lagged correlation procedure calculated significance for TF-
gene pairs, and the significance scores were combined to yield TF cluster scores. 
Position-weight matrices were used to scan the promoter regions of the differentially 
expressed genes and motif enrichments were computed for each cluster. Inferelator 
[151] first formed biclusters based on gene expression data, regulatory motifs in 
promoter regions, and a network of functional associations. Kinetic equations were 
then fit to determine the regulatory impacts between predictor variables, TFs and 
external stimuli, and the biclusters. This method also models pairwise combinatorial 
interactions between predictors. An extension to Inferelator [152] adopts a Bayesian 
approach to improve predictions under long time scales. 
While incorporating sequence data is appealing due to its prevalence in many 
species, motif-based binding predictions are not as informative as experimental 
protein–DNA binding interaction data.  Luscombe et al. [153] presented Statistical 
Analysis of Network Dynamics (SANDY), a tool for calculating network statistics for 
dynamic systems. Differentially expressed genes were assigned to a stage in the cell 
cycle, and an iterative trace-back algorithm was applied to isolate the active TFs and 
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sub-network at that stage. Sub-networks were subsequently compared based on 
graph statistics such as topology, presence of network motifs, and TF usage. Lin et 
al. [154] employed a first-order nonlinear differential equation to combine cell cycle 
TF binding data and dynamic gene expression data and extract dynamic interactions 
among the TFs. Several regression-based methods also include protein–DNA 
binding data to guide the estimation of model parameters. Cokus et al. [155] applied 
linear regression to time series gene expression data and binding interaction data to 
estimate dynamic TF activity levels at each time point. The authors then used least 
squares to estimate a transition matrix that specifies how TFs affect each other’s 
activity levels over time. Multivariate Random Forests, developed by Xiao and Segal 
[156], consist of a random forest of multivariate regression trees that use protein–
DNA binding and motif data as input and temporal gene expression levels as 
outcomes. The resulting proximity matrix specifies pairwise gene similarity based on 
both time series expression and binding information. The authors used the proximity 
matrix as input to a guided clustering method to identify regulatory cliques. 
Probabilistic graphical models have also benefitted from the integration of TF binding 
information. Dynamic Bayesian Networks, discussed in the previous section, were 
adapted to include TF binding data as a prior by Bernard and Hartemink [157] 
The post-transcriptional modification model presented by Shi et al. [158] learns 
temporal TF activity levels via a switching model that determines whether a TF is 
regulated transcriptionaly or post-transcriptionally. TFs’ activity levels can then be 
respectively inferred from either their own gene expression levels or the expression 
levels of their regulatory targets. Below one type of graphical model applied to this 
problem, an extension of HMMs, is described in greater detail. This is the method 
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that was chosen for the prediction of key regulators and regulatory programs during 
hypoxia and macrophage time courses in this project. 
2.2.3. DREM (Dynamic Regulatory Events Miner) 
2.2.3.1. The DREM algorithm 
The analysis of time series microarray data allows us to observe the dynamics of 
gene expression and predict the regulatory programs responsible for the behavior of 
specific groups of genes. DREM is one of the available methods for modeling 
regulatory networks over time [136]. Based on time-series expression data and TF 
binding data (ChiP-Seq in our case), DREM infers the global temporal regulatory 
map – a sequence of paths connecting genes with similar behavior over time. The 
method identifies so called “bifurcation events” – points on the map where genes 
with the same expression up to this point diverge, and predicts the TFs controlling 
these events. 
DREM models gene expression as a set of paths where at each time point each path 
can split into two or more subpaths as a consequence of TF regulation.  Genes are 
associated to a path as a function of the TFs that bind the gene in the regulatory 
network, and similarity in expression to other genes in the path. The model used by 
DREM is based on an Input-Output Hidden Markov Model (IOHMM) [136]: 
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Figure 2. Schema of the DREM method 
Where xt is a set of discrete hidden states at time t, ut is an input vector at time t, yt 
is the output vector at time t. The current inputs and the current state distribution are 
used to estimate the state distribution and the output distribution for the next time 
step. The input vector for each gene is a vector of transcription factor values, 1 if the 
TF is predicted to regulate the gene, and 0 otherwise. As each TF is assumed to 
regulate a gene over the whole time course, the input vector ut has the same values 
for each time point t, i.e. is static. The probabilistic model M is the following set of 
parameters: M = (X, E, Ψ, ϴ, n, γ). 
 n is the number of time points 
 X is the set of hidden states. Each hidden state xt is associated with a 
Gaussian output distribution, fx. 
 ϴ is the set of parameters for the output distributions. For each hidden state x 
∈ X there is an element (μx, σx) ∈ ϴ corresponding to the mean and standard 
deviation of the Gaussian distribution,  fx 
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 E is the set of directed edges connecting hidden states of X, each edge is a 
valid transition among hidden states. This set of edges is constrained to 
enforce a tree structure. Each hidden state can have at most γ children. 
Formally the root of the tree is assumed to have only one state at time point 
0. 
 Ψ contains the parameters controlling transition probabilities between hidden 
states. If a state x ∈ X has 2 or more children, then there is an element ψx ∈ 
Ψ where ψx is a vector of parameters for a logistic regression classifier.  
Let og = (og(1), …, og(n-1)) be the log ratio expression values for gene g at time 
points 1 to n – 1 relative to a time point 0 control. The transition probability for a gene 
g to transition state xb at time point t given that it is in hidden state xa at time point t-
1 is P(Xt = xb | Xt-1 = xa, ug). The logistic regression classifier associated with state 
x maps the static input vector ug, to the transition probabilities for a hidden state xa. 
The likelihood density, L, for a set of genes G for the model M is  
           
 ∈ 
          
   
    ∈ 
         
   
   
                        
Q is the set of all paths of hidden states of length n starting from the root with a non-
zero probability. For a path q ∈ Q, q(i) is the hidden state of the path at time point i.  
The parameter learning step in the model is performed by using a modification of the 
Baum-Welch training algorithm for a regular Hidden Markov Model. During each 
maximization step of the Baum-Welch algorithm each logistic classifier is retrained. 
When training a classifier, for every gene in the training set the classifier is given the 
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probability that the gene is going through the corresponding hidden state based on 
the current values of all the parameters in the model. 
To find the optimal structure for the model, (X, E), a search starts from a single chain 
of hidden states followed by a search over various structures. To train and test these 
structures, the algorithm splits the set of genes into two sets, Gtrain and Gtest. 
Gtrain contains 75% of the genes. The remaining 25% of genes, Gtest, are used for 
scoring the structures. During the parameter maximization the search considers 
adding and deleting paths to the model while L(Gtest | M) increases. After no more 
paths can be added or deleted from the model without improving the test score, the 
weakly supported paths that might be overfitting Gtest are removed through 
randomly resplitting the set of genes used for training and testing. The retrained 
model with the path deleted is compared to the current one. If the score for the new 
model does not change significantly, the old model is replaced by the new one. A 
similar procedure is used to delay splits for which the split could be placed one time 
point later with no significant effect on the score. 
The algorithm then combines the train and test sets and retrains the model on the 
combined set without changing the structure. Genes are assigned to their most likely 
paths using Viterbi algorithm. Paths which have less than 5 genes assigned are 
removed from the model. The splits and paths are then scored for association with 
TFs. The score for a TF is computed using the hypergeometric distribution: 
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where S is the split, A is a path out of the split, nS is the total number of genes 
assigned to the path into the split, nA is the total number of genes on path A out of 
the split, cS is the total number of genes into the split predicted to be regulated by a 
TF, cA is the number of genes on path A. 
2.2.3.2. Advantages and limitations of DREM 
Biological systems are dynamic. The ability of DREM to derive dynamic maps that 
associate TFs with the genes they regulate and their activation time points may lead 
to a better understanding of the system studied and potential prediction of new 
regulatory roles for some of the TFs. As DREM infers the time points at which TFs 
regulate their targets, it can differentiate master regulators that control the immediate 
response to a stimulus from secondary regulators that are active later. Through 
determining the time at which a TF is most active DREM can also identify the best 
time to conduct binding experiments for particular TFs to experimentally verify their 
role in the stimulus response.  
DREM is highly dependent on the input data. The sampling rate may play an 
important role in the ability of the algorithm to derive accurate regulatory maps. The 
models identified by DREM are currently limited to tree structures. DREM also does 
not explicitly model regulation through other mechanisms, such as chromosome 
remodeling and mRNA degradation. Transition probabilities are computed using 
logistic regression, which does not capture all types of combinatorial interactions. 
Another limitation of DREM is that the output dynamic path model is sometimes 
chosen from a number of possible dynamic maps with similar scores.   
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2.3. Data sets 
Hypoxia and re-aeration time course expression data for Nimblegen was generated 
by our collaborators (protocol described in [63], GEO accession number GSE43466) 
and used in the analysis. The whole time course expands from day 0 to day 14. MTB 
is under hypoxia from day 0 to day 7 and under re-aeration from day 7 to day 14 
(Fig.3). 
 
 
Figure 3. Hypoxia profiling. The hypoxia time course is colored in blue, the re-aeration time 
course – in yellow. The red arrows show the time points where samples were taken. 
 
TF binding data from ChIP-Seq experiments for over 80 TFs was used as the second 
type of input for the DREM algorithm. To define the regulatory role of a TF an 
additional overexpression data set of over 200 TFs was used.   
2.4. Data processing and statistical methods 
2.4.1. Microarray data processing 
The hypoxia and re-aeration time course expression data for Nimblegen is a 
combination of 3 separate experiments – 2, 6, 7. The number of replicates used per 
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experiment is shown in the table below. RMA (Robust Multichip Average) with 
background correction and quantile normalization was applied over all probes 
together. The expression values for each day in hypoxia/re-aeration were obtained 
by averaging over the RMA values of all available replicates from corresponding 
experiments. The fold changes are log2 ratios of each day to day 0. P-values for 
differential expression were adjusted with Benjamini-Hochberg method. 
 
  
Total # of 
replicates 
SG2 
replicates 
SG6 
replicates 
SG7 
replicates 
Day 0 11 3 4 4 
Day 1 11 3 4 4 
Day 2 3 3     
Day 3 3 3     
Day 5 3 3     
Day 7 11 3 4 4 
Day 8 11 3 4 4 
Day 9 3 3     
Day12 4     4 
Day14 4   4   
Table 1. Number of replicates per experiment in the hypoxia/re-aeration expression 
data set. 
 
2.4.2. TF binding list 
The TF binding list was generated based on ChIP-Seq data under the threshold of 
1% of maximum impulse coverage for a TF. TF binding sites in intergenic upstream, 
genic upstream and genic in-gene regions were considered. After decomposing the 
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time course expression data into a set of expression paths we compared the path, 
the expression of each TF binding genes in the path, and the predicted regulatory 
role of the TF from the regulatory network to assess the degree to which expression 
patterns might reflect the direct action of transcription factors. To define the 
regulatory role of the TF in the network (activator or repressor) Z-scores from the 
overexpression data set were used. The TF is considered to be an activator if Z-
score > 1, a repressor – if Z-score < -1. If Z-score є [-1, 1], that is considered as a 
weak binding event. Z-score values are generated over the distribution of genes 
whose behavior was affected by the overexpression of the TF. 
2.4.3. DREM parameters 
For building regulatory expression models in this and next chapter the main DREM 
parameters were used with the following values: minimal absolute expression 
change – 1, maximal number of paths out of a split – 3 (higher numbers would 
generate splits that lead to paths with very few genes), convergence likelihood – 
0.01%. Predictions of TFs regulators of bifurcation points with p-values < 0.05 were 
considered significant.  
2.5. Regulatory programs predicted during hypoxia 
DREM was applied to decompose the time course expression data in a nested set of 
paths (Fig. 4, DREM results in Appendix A, Table 2: A). Most of the genes during 
hypoxia are down-regulated. Still, we see 3 paths in which genes are up-regulated 
(especially path1-1). These paths have a considerable number of TFs, and are 
enriched in cholesterol metabolism, sulphate reduction and methylcitrate cycle. The 
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paths of down-regulated genes are enriched in respiration, glycolisis, pentose 
phosphate pathway, cell wall and amino acid biosynthesis. 
Splits (bifurcation points) in DREM expression paths are observed in the first three 
days of the hypoxia time course. DosR and KstR are predicted to be responsible for 
the separation of gene expression patterns in during all three days (Fig. 5). Rv0081, 
Rv1990c, Rv0324, Rv0967, WhiB1 are involved in the change of gene expression 
during day 1 and 2, FurB – day 2 and day 3, the three-component system regulator 
TcrA – day 2, the two-component system regulator MtrA – day 3.   
 
Figure 4. DREM paths during hypoxia/re-aeration. Each path (average expression of all 
the genes in the path over the time course) is assigned a number based on the order and 
amount of preceding bifurcation points. The hypoxia time course is colored in cyan, the re-
aeration time course – in yellow. Pathway enrichment categories in the upper right corner 
refer to upregulated paths, the ones in the bottom right corner – to downregulated paths.  
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Figure 5. TFs predicted by DREM to be responsible for separation in gene expression 
patterns during the hypoxia time course. The days when a bifurcation in expression 
occurs are named with subsequent numbers. 
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2.6. Validation of key regulators and regulatory programs predicted by DREM 
Overexpression microarrays were used as an independent data set to validate some 
of the key regulators and regulatory programs predicted by DREM (by incorporating 
TF binding data and time course expression data). We assessed the degree to which 
expression patterns might reflect the direct action of transcription factors by 
evaluating the consistency between the path, the expression of each TF binding 
genes in the path, and the predicted regulatory role of the TF from the regulatory 
network (based on overexpression data).   
Using this approach, we correctly identify DosR an activator of path 1-3 (Fig. 6).  This 
path corresponds almost entirely to the DosR regulon [17] (43 out of 48 genes in the 
regulon are in the path), and we correctly predict an activator role for DosR and see 
positive correlation between DosR and the genes in this path.   
 
Figure 6. DREM path 1-3 regulated by DosR. The path  is colored in dark blue, the 
expression of DosR – in orange, the expression of the genes in the path which are bound by 
DosR – in light blue. The Venn diagram shows how many of the genes assigned to path 1-3 
belong to the DosR regulon. 
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For KstR, a repressor with known regulon [72], we identify two types of paths that 
KstR is predicted to be the regulator of: a downregulated and an upregulated one 
(Fig. 7, A-B). KstR is upregulated during the hypoxic time course and the genes 
bound by the TF in path 3-1-2 are downregulated (Fig. 7, A). Thus, in this case we 
predict correctly KstR as a repressor of the genes in this path. Path 1-1 has two 
genes with high positive Z-scores for KstR and several genes with low positive Z-
scores (weak binding), i.e. we predict KstR to be also an activator of some genes in 
this path. However, there is also a group of genes that belong to the KstR regulon 
and are known to be repressed by the TF, and still they are upregulated. One reason 
for that can be combinatorial binding, as many of these genes are bound by Rv0081 
and Rv0023 which are activators of these genes. Another hypothesis is that there is 
a factor that leads to the de-repression of KstR. Cholesterol is known to de-repress 
KstR but because no cholesterol was present in the media during the hypoxic time 
course, a potential source of de-repression can be other fatty acids produced in the 
media, such as propionate. 
The third TF for which DREM regulatory predictions were validated, is FurB – a Zn-
dependent repressor with known regulon [162]. FurB was predicted by DREM as one 
of the regulators of the most downregulated path 3-2 (Fig. 8). The genes bound by 
FurB in this path all belong to the regulon of FurB (9 out of 34 genes) and FurB is 
upregulated during the hypoxic time course (Fig. 8). Thus, FurB was validated as a 
repressor of the genes it binds in path 3-2. 
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Figure 7. DREM paths regulated by KstR. A. Downregulated path 3-1-2. B. Upregulated 
path 1-1. Paths are colored in dark lila (A) and pink (B), the expression of KstR – in green, 
the expression of the genes in the path bound by KstR: high positive Z-scores – red, low 
negative Z-scores – dark blue, weak binding – gray.  
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Figure 8. DREM path 3-2 regulated by FurB. The path is colored in dark blue, the 
expression of FurB – in orange, the expression of the genes in the path which are bound by 
FurB – in light blue.  
 
2.7. Identification of Rv0081 as a candidate high-level regulator broadly predictive of 
the overall expression of a set of genes during hypoxia and re-aeration 
Strikingly, we also identify Rv0081 as a candidate high level regulator broadly 
predictive of the overall expression of sets of genes during hypoxia and re-aeration 
(Fig. 9).  In particular, the regulatory role of Rv0081 with respect to individual genes, 
as determined independently by induction, matches the correlation in expression 
between Rv0081 and these genes during hypoxia and re-aeration. Rv0081 is initially 
induced during hypoxia, declines in expression throughout hypoxia, and is expressed 
at low level during re-aeration.  Rv0081 binds 23% to 41% of genes shown in Figure 
9. For path 1-1, which displays genes that are highly activated during hypoxia and 
trend down during re-aeration, 70% of Rv0081 binding is predicted to result in 
activation. Conversely, for path  
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Figure 9. Rv0081 activation/repression ratios for each DREM path during hypoxia. Each 
path is colored according to the color scheme in Fig. 4. The name of each bar consists of the 
name of the path index and the ratio of the number of genes bound by Rv0081 in the path to 
the total number of genes in the path. 
 
3-2, which is highly repressed during hypoxia, 85% of Rv0081 binding is predicted to 
be repressive.  Paths with intermediate levels of activation or repression display 
mixes of activating and repressing Rv0081 binding (Fig. 9).  As a whole, almost a 
linear positive correlation is observed between the number of genes 
activated/repressed by Rv0081 and the behavior of all the genes in the DREM path 
which suggests that Rv0081 regulatory roles are predictive of the expression of 
genes in each path. Thus, a broad regulatory role of Rv0081 is supported by two 
independent sources of evidence: overexpression of RV0081 alters the expression of 
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a large number of genes and the regulatory role of Rv0081, predicted based on 
ChIP-Seq that reveals a large number of binding sites (which are also detected when 
ChIP is performed on Rv0081 during hypoxia) and the time course expression, 
correlates with the expression of bound genes in an independent expression data set 
derived from a significantly different condition. 
Within each path, however, there is substantial variance in expression and not all 
genes are bound by Rv0081.  Part of the variance can be explained by the pattern of 
binding of other TFs.  In most of the paths we can see that a considerable number of 
the genes are bound by several transcription factors. 
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Chapter 3. Comparison of regulatory programs during hypoxia and 
macrophage infection 
3.1. Introduction 
Adaptations to hypoxia has been shown to play an important role in MTB survival in 
the host. However, the pathogen faces other stresses in the phagosome like 
nitrosative stress and pH change. So far in terms of regulation it has been only 
shown that the DosR regulon is induced by NO as well [129-130]. Thus, the second 
aim of this project was to generate a macrophage expression model and compare it 
with the hypoxia model to check how different the expression of genes is in the two 
models and what key regulators are responsible for the common or different 
regulatory programs controlling these genes.  
3.2. Profiling of MTB under conditions other than hypoxia 
3.2.1. Transcriptional response in macrophages 
MTB has been shown to adapt to the phagosome environment of naïve and 
activated macrophages by the induction of fatty acid-degrading enzymes and DNA 
repair proteins, the remodeling of its envelope, and the production of secreted 
siderophores to facilitate the acquisition of iron [66, 124-128]. Schnappinger et al. 
[66] reported the expression of MTB genes in murine macrophages over short-term 
infection out to 2 days. Several functional gene groups were identified that are 
responsible for the MTB metabolic adaptations. The mbt operon, which directs the 
synthesis of mycobacterial siderophores, was upregulated both in resting and 
activated macrophages. Most of these genes were also induced in vitro by NO and 
H2O2, supposedly due to oxidative damage to IdeR, a repressor of the MTB iron 
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scavenging response. Thus, the increased induction of low iron response genes in 
activated macrophages might be caused by NO rather than a decrease in the 
availability of iron in this environment. If that is the case, the NO-mediated induction 
of the iron uptake system could aid in the repair or replacement of damages iron-
containing proteins as a result of the exposure to oxidative and nitrosative stress 
[66]. The ability of MTB to survive in the macrophage phagosome suggests that 
remodeling of the mycobacterial surface should take place. FadD26 and UmaA, 
which might be involved in such remodeling, were identified within the differentially 
expressed genes in the intraphagosomal transcriptome. FadD26 is involved in the 
synthesis of PDIM , which, as mentioned above, serves as a mycobacterial virulence 
factor. UmaA, a protein of unknown function, belongs to a highly conserved family of 
mycolic acid methyl transferases that modify lipids of the mycobacterial cell wall and 
might be important for MTB virulence [66]. Remodeling of the cell envelope appears 
to be accompanied by a DNA recombination and repair response because alkA, 
recX, recG, dinF, and radA were shown to be induced in the phagosome. Moreover, 
the macrophage appears to induce DNA damage independently of NO, as these 
genes were similarly regulated in wildtype and NOS2-deficient macrophages.  
To survive and replicate in naive macrophages MTB must assimilate carbon and 
produce energy in the phagosome. The fact that MTB switches its carbon source 
from glucose and glycerol during in vitro growth to fatty acids in the phagosome was 
supported by the induction of A (CoA) synthase (fadD3,9,10,19), acyl-CoA 
dehydrogenase (fadE5,14,22–24,27–29,31), enoyl-CoA hydratase, (echA19), 
hydroxybutyryl-CoA dehydrogenase (fadB2,3), and acetyl-CoA transferase (fadA5,6) 
[66]. The induction of multiple genes for four of the five transformations suggests that 
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different isoenzymes are required to catabolize structurally diverse fatty acids. 
Breakdown products of fatty acids (acetyl-CoA and propionyl-CoA) are likely 
metabolized via the citric acid and glyoxylate cycles as suggested by the induction of 
the genes gltA1, Rv1130, and icl. Induction of pckA, which encodes the 
gluconeogenetic rate–limiting enzyme phosphoenolpyruvate carboxykinase, 
suggests that fatty acids are in part converted into sugars via gluconeogenesis. 
FadE5, echA19, icl, and pckA and the protein product of Rv1130 were shown to be 
induced in human macrophages or macrophage-like cell lines as well [134]. 
Changes in energy metabolism during macrophage infection are accompanied by 
changes in intermediary metabolism. Genes that encode subunits of NADH 
dehydrogenase (NDH)-1 (nuoABDFIL), the ubiquinol-cytochrome C complex 
(qcrCA), and ATP synthase (atpABDEFGH) were shown to be repressed in both 
murine and human macrophages [66, 124-128]. The repression of genes encoding 
NDH-1, the cytochrome C complex, and the ATP synthase presumably reflects the 
reduced need for energy generation during bacteriostasis, the growth state of 
intraphagosomal MTB, compared with logarithmic growth. By contrast, frdA, narX, 
and ndh, encoding fumarate and nitrate reductases and NDH-2, respectively, were 
shown to be induced. The modulation of the respiratory chain that likely occurs as a 
consequence of the induction of frdA, narX, and ndh could reduce the bioenergetic 
efficiency of the respiratory chain. Alternatively, the induction of these genes could 
signal an increased need for NAD regeneration, the second major function of the 
respiratory chain besides energy production. L-oxidation of fatty acids consumes 
NAD and FADH in every cycle of fatty acid oxidation. Induction of NDH-2, thus, might 
represent an adaptation necessary to ensure NAD levels that are sufficient to allow 
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increased L-oxidation of fatty acids during bacteriostasis. The induction of ald, which 
encodes an l-alanine dehydrogenase, might also contribute to the regeneration of 
NAD because the reductive amination of pyruvate is the kinetically preferred reaction 
at physiological pH [66]. 
More recently, Rohde et al. [126] showed the induction of the same genes involved 
in carbon and fatty acid metabolism, respiration during long-term infection of murine 
macrophages. The group also detected the induction of 17 members of the PhoPR 
regulon, including the acid responsive aprABC locus. The activation of ~60% of the 
DosR regulon and the majority of KstR regulon, including mce4 and igr loci, was 
shown as well. While PDIM and mycolic acids appeared to be downregulated during 
the time course, pks2-papA1 (SL-1) and pks3-pks4-papA3-mmpL10 (PAT/DAT) were 
induced. The enhanced synthesis of SL-1 and PAT/DAT may serve as a sink to 
prevent accumulation of the toxic propionyl-CoA, a byproduct of intracellular fatty 
acid and cholesterol metabolism. WhiB3 as well as espABC (a locus required for 
ESX-1) and its regulator espR were also shown to be induced during the time course 
[126].  
Another group screened for transposon mutants survival in murine macrophages and 
identified essential genes involved in fatty acid metabolism, transporters, 
components of ESX-1 secretion apparatus [126].  
In human THP-1 macrophage cell lines many of the genes involved in carbon, fatty 
acid and iron metabolism, respiration and heat shock overlap [133]. Additional 
groups of genes that were identified: (1) upregulated: mymA operon (restructuring of 
cell envelope), cysD and cysN (synthesis of 3’-phosphoadenosie-5’ incorporated into 
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mycobacterial sulfolipids), drrB, ppsA, ppsB, pks11 (PDIM synthesis and transport), 
pks9 and pks10 (polyketide synthases), ftsW, ftsE, ftsX, ftsH, murC and murG (cell 
division and peptidoglycan assembly), Rv0986 (a component of an ABC transporter), 
esxM, esxG, and esxS (ESAT-6-like proteins), pirG (virulence factor), ideR, whiB3, 
dosR, mprA (TFs), ahpC, ahpD, sodA (oxidative stress); (2) downregulated: Rv0280-
Rv0286 (PE/PPE proteins), whiB2 (TF). 
3.2.2. Transcriptional response to reactive nitrogen and oxygen species 
The DosR regulon was shown to be induced under low concentrations of NO in 
murine macrophages [129-130]. The induction of these genes by both hypoxia and 
NO suggests that MTB encounters one or both of these stresses during the infection 
course in the macrophage. A group of genes that are responsible for oxidative stress 
defense were induced by high concentrations of NO as well as by H2O2 [131]. This 
group includes katG, ahpC, trxC, trxB2, sigB and sigH. Both NO and H2O2 also were 
shown to strongly induce genes involved in iron acquisition (mbt cluster) while bfrB 
gene, encoding the iron-storage protein bacterioferrin, was repressed [130]. The 
genes responding specifically to H2O2 include: recA, radA, alkA, Rv3201c, Rv3202c 
(DNA repair), several PPE/PE genes (PE20, PPE31, PPE32, PPE33, PE33), 
Rv1130 ad gltA1 (propionate metabolism), leuC and leuD (leucine biosynthesis). 12 
genes were shown to be induced specifically under NO exposure including sigE, 
cyp138, Rv0967, lpqA.  
3.2.3. Transcriptional response to nutrient starvation 
The following functional groups of genes were shown to be differentially expressed in 
a nutrient starvation model [131]: (1) upregulated: pdhABC (pyruvate 
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dehydrogenase), frdA (fumarate reductase), pks10, pks2 (SL-1 synthesis), sigB, 
sigE, sigF and sigD (sigma factors), Rv2034, Rv1152, Rv3291c, whiB3, Rv2358 
(TFs), kdpE (a two-component system), subI-cysT-cysW-cysA (sulphur metabolism), 
pirG (cell envelope); (2) downregulated: gap and tpi (glycolisis), fum, can and icd1 
(TCA cycle), nuoA-M, atpA-H (respiration), fas, desA2, desA3, cmaA1 and umaA2 
(mycolic acid biosynthesis), ppsABCDE and mas (PDIM biosynthesis).  
3.2.4. Transcriptional response to acidic conditions   
Under acidic conditions (low pH) in vitro [132], the following main groups of genes 
were shown to be differentially expressed: (1) upregulated: Rv3083-Rv3089 operon 
(peptide synthesis), R1130, Rv1131, fadB2, icl (fatty acid metabolism); (2) 
repressed: Rv3249c (TF), fabD, acpM, kasA, kasB and accD6 (extension of mycolic 
acids).  
3.2. Data sets 
Initially, four different data sets of MTB during macrophage infection were used: 
three microarray data sets (Schnappinger et al. [66], Russell et al. [126] and Tailleux 
et al. [127]) and one RTPCR data set generated by our collaborators. All of these 
data sets are time course experiments, where the time points range from hours to 
days. As the macrophage time course generated by the Russell’s group is one the 
same time scale and has the highest overlap with the hypoxia/re-aeration time 
course in terms of time points (Fig. 10), we chose this data set for the comparison of 
the hypoxia and macrophage models obtained with DREM. Additional microarray 
data set representing MTB under NO and H2O2 stress [130] was used for 
comparison with the hypoxia and macrophage data sets.  
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Figure 10. Macrophage and hypoxia data sets: comparison of time courses. 
3.3. Data processing and statistical methods 
3.3.1. Microarray data processing 
For the microarrays for which raw data was available background correction and 
loess normalization were performed, the expression values of each gene were 
averaged over replicates and fitted to a linear model in R’s limma package. For the 
rest of the microarrays the log ratios provided by the corresponding group were 
used. In all data sets the final log ratios are a result of the comparison of the 
expression values of each time point to the expression values of MTB grown in log 
phase in normal conditions. 
3.3.2. Comparison between expression data sets 
As the microarrays to be compared with each other are from different platform (the 
hypoxia data set is Nimblegen, the other arrays are two-color) and experiments, they 
can’t be compared directly with each other. For the comparison of the log-fold 
changes from each microarray, the values of microarrays with significantly different 
mean and standard deviation from the rest of the data sets, were scaled accordingly 
using the formula: 
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Where k is the index of the k-th dataset to be scaled, std(i) – standard deviation of 
expression values in i-th microarray, X(k) – an array of expression values k-th 
microarray. 
3.4. Pathway enrichment of hypoxia and macrophage models obtained with DREM 
The expression paths in the hypoxia and macrophage models (DREM results in 
Appendix A, Table 2: A-B) were divided into upregulated and downregulated based 
on their gene behavior. First, each of these paths was analyzed for metabolic 
pathway functional enrichment to see if there are paths in the hypoxia and 
macrophage models which are enriched for the same functional categories 
suggesting a similar mechanism for the corresponding metabolic processes. Second, 
we checked if any of the enriched paths have the same regulator assigned to them 
by DREM. 
Both hypoxia and the macrophage model are enriched in methylcitrate cycle, 
cholesterol catabolism (upregulated paths) and respiration (downregulated paths). 
Methylcitrate cycle is one of the toxic propionyl-CoA assimilation which explains why 
upregulated paths in both systems are enriched in genes involved in the cycle. The 
modulation of the respiratory chain caused by the switch from aerobic to anaerobic 
conditions, leads to the downregulation of genes responsible for aerobic respiration 
in both hypoxia and macrophage models. 
The two upregulated paths in both hypoxia and macrophage model, which are 
enriched in cholesterol catabolism, were also predicted by DREM to be regulated by 
the same TF – KstR. Although KstR, which is a repressor, is induced during hypoxia 
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and in the macrophage, and there is no cholesterol in the media in the experiments, 
de-repression of cholesterol degradation genes is observed. As mentioned in chapter 
2, one hypothesis is that short or intermediate chain length fatty acids might be 
generated during hypoxia and in the macrophage, resulting in the de-repression of 
KstR and the induced expression of cholesterol degradation genes. Additionally, as a 
mechanism, although cholesterol is not present in the media, the cholesterol 
degradation pathway may be activated as a result of being coupled with the redox 
stress pathway. Rv0081 which is one of the regulators in the redox stress pathway 
(together with DosR) binds many of the genes (as an activator) in these two paths in 
the hypoxia and the macrophage models. 
Upregulated paths in macrophage models are additionally enriched in genes 
involved in the response to nitrosative stress and lipid metabolism. This observation 
can be explained by the fact that in the macrophage nitrosative stress is present 
unlike in hypoxia, and some genes responsible for complex lipid synthesis (PAT/DAT 
and SL-1, results presented in 3.6) are upregulated in the macrophage models but 
downregulated in hypoxia. 
3.5. Regulators predicted to be responsible for the expression of genes in the early 
stages of both hypoxia and macrophage models  
Both in hypoxia and macrophage models DosR and KstR were predicted as the 
regulators responsible for the expression of genes in the early stages (up to day 2) of 
the time courses (Fig. 11). This prediction agrees with the finding of DosR being the 
regulator of the initial hypoxic response [61, 64] (and also induced by NO [65]). KstR, 
which controls genes responsible for cholesterol degradation and lipid metabolism 
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and is induced in both hypoxia and the macrophage, is potentially involved in the 
initial stage of the response in both types of models as well. 
 
 
Figure 11. DREM predictions for DosR and KstR as key regulators during the early 
stages of both hypoxia and macrophage models. KstR and DosR were predicted as key 
regulators up to day 2 in both hypoxia and macrophage time courses. The color of the boxes 
corresponds to the color of the path the TFs are assigned to in the model. 
 
3.6. Genes, involved in the synthesis of SL-1, PAT/DAT and regulated by PhoP, 
have opposite expression patterns in hypoxia and macrophage models 
A group of genes that are involved in the synthesis of complex lipids: pks2, papA1 
(SL-1 synthesis), pks3, pks4 and papA3 (PAT/DAT synthesis), was identified to be 
downregulated in the hypoxia model and upregulated (differentially expressed) in the 
macrophage model (Fig. 12). These genes belong to the two most upregulated 
DREM paths in the macrophage model (Fig. 13). Moreover, PhoP is predicted by 
DREM as the regulator of one of these paths (the most upregulated one). All of these 
genes are also downregulated in the PhoP mutant [78] and pks2, pks3, pk4 and 
papA3 have been reported to be part of its regulon [89] and are bound by PhoP in 
our Chip-Seq data. PhoP stay at low levels in hypoxia but is upregulated in the 
macrophage (Fig. 14, A). 
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Figure 12. Clustergram of the group of genes which has a different behavior in hypoxia 
and macrophage models. Hypoxia/Re-aeration – the hypoxia/re-aeration time course, 
Macrophage – macrophage infection time course expression data generated by Russell’s 
group, PhoP KO – PhoP knock-out microarray, NO – expression data set where MTB was 
exposed to different concentrations of nitric oxide (nitrosative stress). 
 
 
 
Figure 13. Genes involved in complex lipid biosynthesis and the upregulated DREM 
paths in the macrophage model that they are associated with.  
Interestingly, this group of genes is downregulated or does not change significantly in 
the microarray data set where MTB was exposed to nitrosative stress. Additionally, 
the action of PhoP has been shown to be pH-dependent [78]. Thus, one hypothesis 
is that PhoP is the potential regulator of the genes involved in SL-1 and PAT/DAT 
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biosynthesis as a result of pH change that takes place in the macrophage 
environment but not during hypoxia.  It’s possible that PAT/DAT and SL-1 precursors 
(the transporters mmpL8 and mmpL10, which are needed for the final step of the 
lipid synthesis, are not upregulated in the macrophage models) serve only as a 
metabolic adaptation (reserve energy and carbon source) to the granuloma 
environment. In murine models of chronic and progressive pulmonary TB SL-1 and 
PAT/DAT have been shown to be over-produced possibly because they play a role in 
virulence [161]. 
3.7. Additional regulators whose action can explain the specific behavior of genes 
responsible for SL-1, PAT/DAT synthesis in hypoxia versus macrophage infection 
Based on our TF network, PhoP is only one of the TFs which bind the genes 
responsible for complex methyl-branched lipid biosynthesis. A more complicated 
mechanism may be involved in the regulation of pks2 and pks3 polyketide 
synthases. In our binding network PhoP binds WhiB3 and both TFs bind pks2 and 
pks3 and have been shown to modulate the production of PAT/DAT and SL-1 [78, 
89, 92, 93]. In the hypoxia model PhoP stays at low levels while WhiB3 is 
upregulated, but both TFs are upregulated in the macrophage models (Fig. 11) and 
that is where upregulation of pks2 and pks3 is observed. That observation leads to 
the hypothesis that PhoP and WhiB3 form a feed-forward loop (FFL) and both TFs 
need to be activated for the induction of pks2 and pks3  which control the first step in 
the biosynthesis of SL-1 and PAT/DAT respectively.  
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Figure 14. PhoP and WhiB3 time course expression and FFL. A: Expression in hypoxia 
and RTPCR macrophage models. B: FFL structure.  
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Chapter 4. Discussion 
4.1. Conclusions 
This work describes the identification of temporal expression trends during hypoxic 
and macrophage time courses and their association with possible key regulators and 
regulatory programs with the incorporation of microarray, ChIP-Seq and TF 
overexpression data. Thus, the first dynamic regulatory models for hypoxia and 
macrophage infection were built. The results presented confirm already known key 
regulators like DosR, KstR and FurB (predictions were validated on the 
overexpression data set) as well as provide new insight about regulators like Rv0081 
for which no data has been reported in the literature. Rv0081 was found to be a 
candidate high level regulator broadly predictive of the overall expression of sets of 
genes during both normoxia and hypoxia. 
DosR and KstR were predicted as the regulators responsible for the expression of 
genes in the early stages (up to day 2) of both hypoxia and macrophage models. 
Along with similar trends in the expression of genes involved in respiration, 
cholesterol catabolism and methylcitrate cycle, a direct comparison between the 
hypoxia and macrophage expression models uncovered a potential condition-
specific regulatory program controlling a group of genes responsible for the 
synthesis of complex methyl-branched lipids (PAT/DAT and SL-1). PhoP is the 
potential regulator in this program predicted to activate these genes as a result of 
pH change which takes place in the macrophage environment but not during 
hypoxia. A more complex mechanism for pks2 and pks3 might involve the cross-talk 
between PhoP and WhiB3 forming a FFL identified in our transcriptional regulatory 
network.  
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4.2. Future directions 
As one of the central findings in this work is connected to revealing the 
transcriptional regulatory mechanisms behind metabolic adaptations of MTB 
involving complex lipids biosynthesis, the hypothesis of PhoP being a condition-
specific regulator of SL-1 and PAT/DAT synthesis can be followed up by 
experimental validation. One of the experiments for the validation of this hypothesis 
can be profiling wild type MTB with and a PhoP knock-out at least in two conditions – 
hypoxia and acidic pH, with additional conditions being NO exposure and 
macrophage infection. Chromatography experiments with complex lipid extraction 
(SL-1 and PAT/DAT) in the same conditions can be conducted as well. 
A method like single cell microfluidics can be used to identify and analyze the 
dynamics of the potential FFL between PhoP and WhiB3.  
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Appendices 
APPENDIX A 
Table 2. DREM TF predictions for hypoxia and macrophage time courses. 
A. Hypoxia 
Path Name TF P-value 
path1 Rv3133c 1.45E-18 
path1 Rv1255c 1.45E-05 
path1 Rv0324 8.11E-04 
path1 Rv1994c 0.01 
path1 Rv0474 0.014 
path1 Rv1985c 0.023 
path1 Rv3574 0.032 
path1 Rv1956 0.035 
path1 Rv2610c 0.039 
path1 Rv0081 0.046 
path2 Rv2021c 2.91E-03 
path2 Rv0465c 4.58E-03 
path2 Rv1990c 0.041 
path3 Rv0967 4.31E-09 
path3 Rv3249c 7.18E-07 
path3 Rv1049 1.47E-05 
path3 Rv3219 2.99E-03 
path3 Rv0767c 3.00E-03 
path3 Rv2324 4.35E-03 
path3 Rv2887 9.95E-03 
path3 Rv2034 0.027 
path3 Rv0653c 0.042 
path1-1 Rv0602c 3.50E-03 
path1-1 Rv2324 0.023 
path1-2 Rv3574 1.16E-03 
path1-2 Rv1985c 7.81E-03 
path1-2 Rv1990c 0.013 
path1-2 Rv2610c 0.04 
path1-2 Rv0324 0.044 
path1-3 Rv3133c 2.30E-10 
path1-3 Rv2359 2.47E-03 
path1-3 Rv3066 2.47E-03 
path1-3 Rv0967 0.027 
77 
 
 
 
path2-1 Rv3597c 2.72E-03 
path2-1 Rv0602c 0.012 
path2-1 Rv0653c 0.017 
path2-2 Rv1049 4.81E-04 
path3-1 Rv3066 2.11E-03 
path3-1 Rv3574 0.01 
path3-1 Rv0081 0.019 
path3-1 Rv0465c 0.023 
path3-1 Rv1956 0.043 
path3-2 Rv3219 3.52E-07 
path3-2 Rv0967 8.01E-04 
path3-2 Rv2359 0.022 
path2-1-1 Rv0324 1.46E-04 
path2-1-1 Rv3133c 4.30E-04 
path2-1-1 Rv0081 5.77E-03 
path2-1-1 Rv0494 6.06E-03 
path2-1-1 Rv3597c 0.03 
path2-1-2 Rv3574 0.03 
path2-2-1 Rv3249c 6.78E-03 
path2-2-2 Rv0494 0.024 
path3-1-1 Rv1255c 3.48E-03 
path3-1-1 Rv0602c 0.011 
path3-1-1 Rv3133c 0.016 
path3-1-1 Rv1985c 0.021 
path3-1-1 Rv1994c 0.021 
path3-1-1 Rv3249c 0.033 
path3-1-1 Rv3246c 0.034 
path3-2-1 Rv1255c 3.74E-03 
path3-2-1 Rv0324 0.011 
path3-2-1 Rv3574 0.021 
path3-2-2 Rv3597c 1.19E-04 
path3-2-2 Rv0494 9.16E-03 
path3-2-2 Rv3246c 0.018 
path3-2-2 Rv0767c 0.026 
path3-2-2 Rv2359 0.048 
path3-1-2-2 Rv0494 3.79E-04 
path3-1-2-2 Rv0081 1.69E-03 
path3-1-2-2 Rv2610c 4.92E-03 
path3-1-2-2 Rv0653c 0.022 
path3-1-2-2 Rv0767c 0.029 
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path3-1-2-2 Rv0465c 0.032 
path3-1-2-2 Rv2989 0.036 
path3-1-2-3 Rv1049 2.67E-03 
path3-1-2-3 Rv2324 6.16E-03 
 
B. Macrophage 
Path 
Name TF P-value 
path1 Rv3133c 0.011 
path1 Rv3574 0.012 
path1 Rv3066 0.016 
path1 Rv2887 0.018 
path2 Rv0757 1.06E-03 
path2 Rv1255c 1.84E-03 
path2 Rv3597c 0.016 
path2 Rv2989 0.019 
path3 Rv3219 2.88E-03 
path3 Rv0494 4.62E-03 
path1-1 Rv0967 9.88E-04 
path1-2 Rv0653c 7.48E-03 
path1-2 Rv1994c 0.032 
path2-1 Rv0324 1.57E-06 
path2-1 Rv0081 1.10E-03 
path2-1 Rv0757 2.56E-03 
path2-1 Rv3597c 4.58E-03 
path2-1 Rv0767c 7.24E-03 
path2-1 Rv2989 8.82E-03 
path2-1 Rv1255c 0.032 
path2-2 Rv2324 0.041 
path3-1 Rv3133c 8.22E-03 
path3-2 Rv2034 5.10E-03 
path3-2 Rv1049 6.62E-03 
path3-2 Rv2324 0.043 
path3-2 Rv0081 0.045 
path3-1-1 Rv0967 0.028 
path3-2-1 Rv0967 1.62E-03 
path3-2-2 Rv0465c 0.039 
path3-2-3 Rv0324 0.019 
path3-2-3 Rv0767c 0.045 
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